ࡱ> q` bjbjqPqP ::RRRRT DfffflgN iiiiiOoNrs|$ htvznOozzRRiiƃ~~~z$Rlii~z~~4,Wii Ҭ]fB~RG܃0 O~WWk tdqu~ov;w t t t~ t t t zzzzNNNdDNNNd>& RRRRRR  APPENDIX C FOOD AND DRUG INTERACTIONS THIS SECTION IS TO ASSIST THE CRMA IN CHOOSING APPROPRIATE FOODS TO MIX MEDICATIONS WITH WHEN NEEDED, AND TO HELP THEM RECOGNIZE WHAT MAJOR FOODS INTERACT WITH THE MAJOR CLASSIFICATIONS OF DRUGS UTILIZED IN THE RESIDENTIAL CARE SETTING. Remember that whenever you add a medication to a soft food and the food or medication change, or begin to change color, a chemical reaction is occurring that may affect the therapeutic action of the drug. DRUG/FOOD CAUTIONS Avoid drastic changes in dietary habit. Consult your doctor before taking large amounts of Vitamin K (Green leafy vegetables). Avoid alcohol. Avoid sugar and sugary food. Avoid bran and high fiber foods within 2 hours of taking this medication. Take 30-60 minutes before meals. Avoid excess salt/sodium unless otherwise instructed by your physician. Avoid salt substitutes containing potassium. Avoid milk, calcium containing dairy products, iron, antacids, or aluminum salts 2 hours before or 6 hours after using antacids while on this medication. No iron within 4 hours of taking this medication. Avoid aged foods (cheese, red wine), pickled foods, cured foods (bacon/ham), chocolate, fava beans, beer, unless approved by your physician. Take with food. Do not change your salt intake from day to day without telling your doctor. Take on empty stomach: 1 hour before or 2 hours after meals. Increase potassium intake; add a banana or orange juice; unless instructed otherwise. Take this medication either consistently with or without food as instructed by your doctor. Take with a full glass of water Avoid dairy products, eggs, cereals and whole grains within 2 hours of taking this medication. Avoid excessive quantities of coffee or tea (Caffeine). Take this medication with a high fat meal. Take this medication 30 minutes before meals. Avoid taking with grapefruit juice. To avoid constipation: increase your daily intake of fiber (beans, whole grains, vegetables). No iron, zinc or fluoride within 2 hours of taking this medication. May take Vitamin D. Do not take supplements containing Vitamin A. Avoid natural licorice. Do not take Aluminum or magnesium antacids or supplements while on this medication. Do not take calcium, aluminum, magnesium or Iron supplements within 2 hours of taking this medication. Absorption may be decreased with foods high in oxalate (spinach, sweet potatoes, beans, nuts) and phytate (unleavened bread and grains). Take with low fat meal. Do not take with milk. Take 30-60 minutes before breakfast. Take after a full meal. Increase dietary intake of magnesium, folate, vitamin B6, B12, and/or consider taking a multivitamin. Avoid iodine supplements. Avoid St. Johns Wort. Dissolve under the tongue. Take at the same time everyday. Limit garlic, ginger, gingko, and horse chestnut. Avoid avocado. __________________________________________ Please note that certain dietary supplements including herbal products may negatively interact with your medications. Consult your physician before using any of these products. ________________________________________ If you would like more information about food and drug interactions or have other questions about your medications, please ask your HUHS physician or pharmacist.  Food and Drug Interactions Harvard University Health Services 12/03 Acetaminophen (Tylenol)3 Acetazolamide (Diamox).12 Alendronate (Fosamax)..17,32 Allopurinol (Zyloprim)..17 Alprazolam (Xanax)..3,12,19,22 Amantadine (Symmetrel).3 Amiloride (Midamor).1,8,12,26 Amitriptyline (Elavil) 3,12,19,36 Amlodipine (Norvasc)..22,26 Aspirin..1,2,3,12,17 Atenolol (Tenormin)..2,6 Atorvastatin (Lipitor).1,3,22,30 Azithromycin (Zithromax).14,27 Bethanecol (Urecholine)...14 Bromocriptine (Parlodel)..3,12 Bupropion (Wellbutrin)..3,36 Buspirone (Buspar)..3,12,22 Butalbital w/ Caffeine + Acetaminophen (Fioricet)..3 Butabital w/ Caffeine + Aspirin (Fiorinal)...3,12 Calcium Carbonate(Tums)...3,12,17,19,24,29 Captopril (Capoten)..3,8,14,26,28 Carbamazepine (Tegretol)..3,12,22 Carvedilol (Coreg).12 Cephalexin (Keflex).14 Cetirizine (Zyrtec).3 Choline Magnesium Salicylate (Trilisate)...12,17 Ciprofloxacin (Cipro)...9,17,19 Citalopram (Celexa).3,36 Clonazepam (Klonopin).3,12,19 Codeine (Tylenol#3)...3,12,23 Conjugated Estrogen (Premarin, Estrace). 3,12,19 Cyclobenzaprine (Flexaril)..3 Cyclosporine (Neoral).8,22,38 Desipramine (Norpramin)..3 Dexamethasone (Decadron).3,12,22 Diazepam (Valium)..3,12,19,22 Dichloralphenazone/Isometheptene/Acetaminophen (Midrin)3 Dicyclomine (Bentyl)...3,21 Didanosine, DDI (Videx)..3,14 Digoxin (Lanoxin)..5,7,8,9,39 Diltiazem (Cardizem CD).21,26 Dimenhydrinate (Dramamine)...3,12 Diphenhydramine HCL (Benadryl)...3,12 Diphenoxylate/Atropine (Lomotil).3,12 Donepezil (Aricept)3 Doxazosin (Cardura)..3,26 Doxepin (Sinequan)...3,12,19,36 Doxycycline (Vibramycin)3,9,17,28 Ergotamine w/ Caffeine (Cafergot).3,19,22 Erythromycin (EryTab,EES,Emycin)..3,14,17,22 Ferrous Sulfate (Iron)..3,5,9,14,17,18 Fludrocortisone (Florinef)7 Fluphenazine (Prolixin).3,12 Fosinopril (Monopril)..3,8,26,28 Furosemide (Lasix)....3,7,15 Glipizide (Glucotrol).3,4,32 Glyburide (Micronase)...3,4,32 Griseofulvin (Fulvacin)20 Guaifenesin (Robitussin)..17 Guaifenesin + Codeine...3,12,17 Hydrochlorothiazide (Hydrodiuril)..3,7,12,15,26,28 Hydrocodone/Acetaminophen (Vicodin)...3,12,23 Hydroxychloroquine Sulfate (Plaquenil)...12 Hydroxyzine (Atarax)..3 Ibuprofen (Motrin, Advil)..3,12 Imipramine (Tofranil)..3,12,19,36 Indinavir (Crixivan)....14,17,22 Indomethacin (Indocin)...3,12 Isoniazid.3,11,14,17,28,34 Isotretinoin (Accutane)..3,12,17,25 Itraconazole (Sporanox)..9,12,22,33 Ketoconazole (Nizoral)..3,9,12 Lansoprazole (Prevacid)3,6 Levothyroxine (Levoxyl,Synthroid)..10,32 Lisinopril (Zestril, Prinivil)...3,7,8,26 Lithium (LithoTab, Eskalith)3,12,13,19,35 Loratadine (Claritin).14 Lorazepam (Ativan).3,12,19 Lovastatin (Mevacor).1,3,12,22 Mebendazole (Vermox).12 Medroxyprogesterone (Provera)12 Mefloquine (Lariam).....3,12,17 Megestrol (Megace)...12 Metformin (Glucophage)...3,12 Methocarbamol (Robaxin).3 Methyldopa (Aldomet).3,24,26,34 Methylphenidate (Ritalin)..3,14,19 Metoprolol (Lopressor,Toprol XL)...3,12,26 Metronidazole (Flagyl).3,12 Minocycline (Minocin)12,27 Morphine (MS-IR, MS-Contin)..3,12,23 Mycophenolate (Cellcept).14,28 Nabumetone (Relafen)..3,12 Nadolol (Corgard)..3,26 Naproxen (Naprosyn, Aleve).3,12,17 Nefazodone (Serzone)3,16,39 Nelfinvir (Viracept).12 Niacin (Vitamin B3)..3,12 Nifedipine (Procardia XL, Adalat)3,22,26,30 Nitrofurantoin (Macrodantin).12 Nitroglycerine (Nitrostat).3,14,37 Nizatidine (Axid).3,19,24,27 Nortriptyline (Pamelor).3,12,19 Olanzapine (Zyprexa)3 Omeprazole (Prilosec)..3,6 Oral Contraceptives.3,12,19,34,38 Oxazepam (Serax)..3,12,19 Oxybutynin (Ditropan, XL).3,12 Percocet (Roxicet).3,12,23 Perphenazine (Trilafon)3,12,28 Phenazopyridine (Pyridium).12 Phenelzine (Nardil)..3,11,19,36 Phenobarbital3,19,34 Phenytoin (Dilantin).3,12,28 Potassium Chloride (K-Dur)..17,33 Pravastatin (Pravachol).1,3 Prazosin (Minipress).3,26 Prednisone (Deltasone).3,12,22 Prochlorperazine (Compazine).3,12,17,19 Promethazine w/ Codeine (Phenergan).3,12,23 Propranolol (Inderal).3,12,26 Propylthiouracil (PTU)38 Psyllium (Metamucil)..17 Raloxifene (Evista).3 Ranitidine (Zantac)3,9,19 Rifampin (Rifadin)..3,14,17 Ritonavir (Norvir)..12,36 Saquinavir (Invirase)33 Sertraline (Zoloft)....3,12,22,36 Sildenafil (Viagra)..14 Simethicone (Mylicon).33 Simvastatin (Zocor)..1,3.22 Spironolactone (Aldactone)...3,8,12 Spironolactone + HCTZ (Aldactazide).....3,8,12,26,28 Sucralfate (Carafate)..3,14,17,28 Sulfamethoxazole/Trimethoprim (Bactrim)14,17,28 Sulfasalazine (Azulfidine).12,17,24 Temazepam (Restoril)3,19,40 Tetracycline (Sumycin).9,14,17 Theophylline (Theodur).3,12,19 Thyroid Desiccated10,32 Tolterodine (Detrol).12 Tranylcypromine (Parnate)...3,11,19,36 Trazodone (Desyrel)...3,12,36 Typhoid Vaccine (Vivotif Berna)....14,17 Ursodiol (Actigall)..12 Valproic Acid (Depakote).3,12,31 Venlafaxine (Effexor, XR)...3,12,36 Verapamil (Calan)..3,12,19,22,26 Warfarin (Coumadin)..1,2,3,36,39 Zafirlukast (Accolate)....14 Zalcitabine (Hivid).14,28 Zolpidem (Ambien)..3,32 Food & Drug Interactions  Medicines can treat and cure many health problems. However, they must be taken properly to ensure that they are safe and effective. Many medicines have powerful ingredients that interact with the human body in different ways, and diet and lifestyle can sometimes have a significant impact on a drug.s ability to work in the body. Certain foods, beverages, alcohol, caffeine, and even cigarettes can interact with medicines. This may make them less effective or may cause dangerous side effects or other problems. When you take medicine, be sure to follow your doctor.s instructions carefully to obtain the maximum benefit with the least risk. Changes in a medicine.s effect due to an interaction with food, alcohol or caffeine can be significant; however, there are many individual factors that influence the potential for such variations, like dose, age, weight, sex, and overall health. This brochure has information about possible interactions between many common prescription and nonprescription (over-thecounter) medications with food, alcohol and caffeine. But this brochure should not replace the advice from your physician, pharmacist, or other health care professional. If you have any questions or concerns about possible drug interactions, consult your health care professional. Make sure your doctor and pharmacist know about every drug you are taking, including nonprescription drugs and any dietary supplements such as vitamins, minerals and herbals. If you have problems or experience side effects related to medication, call your health care provider right away. It is also important to remember that many drugs interact with other drugs and may cause serious medical conditions. In this brochure, the generic (nonproprietary) name for each drug is stated first. Brand names are in full capital letters and represent only some examples of those medications. ALLERGIES Antihistamines are used to relieve or prevent the symptoms of colds, hay fever, and allergies. They limit or block histamine, which is released by the body when we are exposed to substances that cause allergic reactions. Antihistamines are available with and without a prescription (overthe- counter). These products vary in their ability to cause drowsiness and sleepiness. ANTIHISTAMINES Some examples are: Over the Counter: brompheniramine / DIMETANE, BROMPHEN chlorpheniramine / CHLOR-TRIMETON diphenhydramine / BENADRYL clemastine/TAVIST Prescription: fexofenadine / ALLEGRA loratadine / CLARITIN cetirizine / ZYRTEC astemizole/HISMANAL Interaction Food: It is best to take prescription antihistamines on an empty stomach to increase their effectiveness. Alcohol: Some antihistamines may increase drowsiness and slow mental and motor performance. Use caution when operating machinery or driving. ARTHRITIS AND PAIN ANALGESIC/ANTIPYRETIC They treat mild to moderate pain and fever. An example is: acetaminophen/TYLENOL, TEMPRA Interactions Food: For rapid relief, take on an empty stomach because food may slow the body.s absorption of acetaminophen. Alcohol: Avoid or limit the use of alcohol because chronic alcohol use can increase your risk of liver damage or stomach bleeding. If you consume three or more alcoholic drinks per day talk to your doctor or pharmacist before taking these medications. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) NSAIDs reduce pain, fever, and inflammation. Some examples are: aspirin/BAYER, ECOTRIN ibuprofen/MOTRIN, ADVIL naproxen/ANAPROX, ALEVE, NAPROSYN ketoprofen/ORUDIS nabumetone/RELAFEN Interaction Food: Because these medications can irritate the stomach, it is best to take them with food or milk. Alcohol: Avoid or limit the use of alcohol because chronic alcohol use can increase your risk of liver damage or stomach bleeding. If you consume three or more alcoholic drinks per day talk to your doctor or pharmacist before taking these medications. Buffered aspirin or enteric coated aspirin may be preferable to regular aspirin to decrease stomach bleeding. CORTICOSTEROIDS They are used to provide relief to inflamed areas of the body. Corticosteroids reduce swelling and itching, and help relieve allergic, rheumatoid, and other conditions. Some examples are: methylprednisolone/MEDROL prednisone/DELTASONE prednisolone/PEDIAPRED, PRELONE cortisone acetate/CORTEF Interaction Food: Take with food or milk to decrease stomach upset. NARCOTIC ANALGESICS Narcotic analgesics are available only with a prescription. They provide relief for moderate to severe pain. Codeine can also be used to suppress cough. Some of these medications can be found in combination with non-narcotic drugs such as acetaminophen, aspirin, or cough syrups. Use caution when taking these medications: take them only as directed by a doctor or pharmacist because they may be habit forming and can cause serious side effects when used improperly. Some examples are: codeine combined with acetaminophen/ TYLENOL #2,#3,& #4 morphine/ROXANOL, MS CONTIN oxycodone combined with acetaminophen/ PERCOCET, ROXICET meperidine/DEMEROL hydrocodone with acetaminophen/ VICODIN, LORCET Interaction Alcohol: Avoid alcohol because it increases the sedative effects of the medications. Use caution when motor skills are required, including operating machinery and driving. ASTHMA BRONCHODILATORS Bronchodilators are used to treat the symptoms of bronchial asthma, chronic bronchitis and emphysema. These medicines open air passages to the lungs to relieve wheezing, shortness of breath and troubled breathing. Some examples are: theophylline / SLO-BID, THEO-DUR, THEO-DUR 24, UNIPHYL, albuterol / VENTOLIN, PROVENTIL, COMBIVENT epinephrine/PRIMATENE MIST Interactions Food: The effect of food on theophylline medications can vary widely. High-fat meals may increase the amount of theophylline in the body, while high-carbohydrate meals may decrease it. It is important to check with your pharmacist about which form you are taking because food can have different effects depending on the dose form (e.g., regular release, sustained release or sprinkles) For example, food has little effect on Theo-Dur and Slo-Bid, but food increases the absorption of Theo-24 and Uniphyl which can result in side effects of nausea, vomiting, headache and irritability. Food can also decrease absorption of products like Theo-Dur Sprinkles for children. Caffeine: Avoid eating or drinking large amounts of foods and beverages that contain caffeine (e.g., chocolate, colas, coffee, tea) because both oral bronchodilators and caffeine stimulate the central nervous system. Alcohol: Avoid alcohol if you.re taking theophylline medications because it can increase the risk of side effects such as nausea, vomiting, headache and irritability. CARDIOVASCULAR DISORDERS There are numerous medications used to treat cardiovascular disorders such as high blood pressure, angina, irregular heart beat, and high cholesterol. These drugs are often used in combination to enhance their effectiveness. Some classes of drugs can treat several conditions. For example, beta blockers can be used to treat high blood pressure, angina, and irregular heart beats. Check with your doctor or pharmacist if you have questions on any of your medications. Some of the major cardiovascular drug classes are: DIURETICS Sometimes called water pills, diuretics help eliminate water, sodium, and chloride from the body. There are different types of diuretics. Some examples are: furosemide/LASIX triamterene/hydrochlorothiazide/ DYAZIDE, MAXZIDE hydrochlorothiazide/HYDRODIURIL triamterene/DYRENIUM bumetamide/BUMEX metolazone/ZAROXOLYN Interaction Food: Diuretics vary in their interactions with food and specific nutrients. Some diuretics cause loss of potassium, calcium, and magnesium. Triamterene, on the other hand, is known as a potassium-sparing diuretic. It blocks the kidneys excretion of potassium, which can cause hyperkalemia (increased potassium). Excess potassium may result in irregular heartbeat and heart palpitations. When taking triamterene, avoid eating large amounts of potassium-rich foods such as bananas, oranges and green leafy vegetables, or salt substitutes that contain potassium. BETA BLOCKERS Beta blockers decrease the nerve impulses to the heart and blood vessels. This decreases the heart rate and the work load of the heart. Some examples are: atenolol/TENORMIN metoprolol/LOPRESSOR propranolol/INDERAL nadolol/CORGARD Interaction Alcohol: Avoid drinking alcohol with propranolol/INDERAL because the combination lowers blood pressure too much. NITRATES Nitrates relax blood vessels and lower the demand for oxygen by the heart. Some examples are: isosorbide dinitrate/ISORDIL, SORBITRATE nitroglycerin/NITRO, NITRO-DUR, TRANSDERM-NITRO Interaction Alcohol: Avoid alcohol because it may add to the blood vessel-relaxing effect of nitrates and result in dangerously low blood pressure. ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS ACE inhibitors relax blood vessels by preventing angiotensin II, a vasoconstrictor, from being formed. Some examples are: captopril/CAPOTEN enalapril/VASOTEC lisinopril/PRINIVIL, ZESTRIL quinapril/ACCUPRIL moexipril/UNIVASC Interactions Food: Food can decrease the absorption of captopril and moexipril. So take captopril and moexipril one hour before or two hours after meals. ACE inhibitors may increase the amount of potassium in your body. Too much potassium can be harmful. Make sure to tell your doctor if you are taking potassium supplements or diuretics (water pills) that may increase the amount of potassium in your body. Avoid eating large amounts of foods high in potassium such as bananas, green-leafy vegetables, and oranges. HMG-COA REDUCTASE INHIBITORS Otherwise known as statins, these medications are used to lower cholesterol. They work to reduce the rate of production of LDL (bad cholesterol). Some of these drugs also lower triglycerides. Recent studies have shown that pravastatin can reduce the risk of heart attack, stroke, or miniature stroke in certain patient populations. Some examples are: atorvastatin/LIPITOR cerivastatin/BAYCOL fluvastatin/LESCOL lovastatin/MEVACOR pravastatin/PRAVACHOL simvastatin/ZOCOR Interaction Alcohol: Avoid drinking large amounts of alcohol because it may increase the risk of liver damage. Food: Lovastatin (Mevacor) should be taken with the evening meal to enhance absorption. ANTICOAGULANTS Anticoagulants help to prevent the formation of blood clots. An example is: warfarin/COUMADIN Interactions Food: Vitamin K produces blood-clotting substances and may reduce the effectiveness of anticoagulants. So limit the amount of foods high in vitamin K (such as broccoli, spinach, kale, turnip greens, cauliflower, and brussel sprouts). High doses of vitamin E (400 IU or more ) may prolong clotting time and increase the risk of bleeding. Talk to your doctor before taking vitamin E supplements. INFECTIONS ANTIBIOTICS AND ANTIFUNGALS Many different types of drugs are used to treat infections caused by bacteria and fungi. Some general advice to follow when taking any such product is: . Tell your doctor about any skin rashes you may have had with antibiotics or that you get while taking this medication. A rash can be a symptom of an allergic reaction, and allergic reactions can be very serious. . Tell your doctor if you experience diarrhea. . If you are using birth control, consult with your health care provider because some methods may not work when taken with antibiotics. . Be sure to finish all your medication even if you are feeling better. . Take with plenty of water. ANTIBACTERIALS PENICILLIN Some examples are: penicillin V / VEETIDS amoxicillin / TRIMOX, AMOXIL ampicillin / PRINCIPEN, OMNIPEN Interaction Food: Take on an empty stomach, but if it upsets your stomach, take it with food. QUINOLONES Some examples are: ciprofloxacin / CIPRO levofloxacin / LEVAQUIN ofloxacin / FLOXIN trovafloxacin / TROVAN Interactions Food: Take on an empty stomach one hour before or two hours after meals. If your stomach gets upset, take it with food. However, avoid calcium-containing products like milk, yogurt, vitamins or minerals containing iron, and antacids because they significantly decrease drug concentration. Caffeine: Taking these medications with caffeinecontaining products (e.g., coffee, colas, tea, and chocolate) may increase caffeine levels, leading to excitability and nervousness. CEPHALOSPORINS Some example are: cefaclor / CECLOR, CECLOR CD cefadroxil / DURICEF cefixime / SUPRAX cefprozil / CEFZIL cephalexin / KEFLEX, KEFTAB Interaction Food: Take on an empty stomach one hour before or two hours after meals. If your stomach gets upset, take with food. MACROLIDES Some examples are: azithromycin / ZITHROMAX clarithromycin / BIAXIN erythromycin / E-MYCIN, ERY-TAB, ERYC erythromycin + sulfisoxazole /PEDIAZOLE Interaction Food: Take on an empty stomach one hour before or two hours after meals. If your stomach gets upset, take with food. SULFONAMIDES An example is: sulfamethoxazole + trimethoprim / BACTRIM, SEPTRA Interaction Food: Take on an empty stomach one hour before or two hours after meals. If your stomach gets upset, take with food. TETRACYCLINES Some examples are: tetracycline / ACHROMYCIN, SUMYCIN doxycycline / VIBRAMYCIN minocycline / MINOCIN Interaction Food: Take on an empty stomach one hour before or two hours after meals. If your stomach gets upset, take with food. However, it is important to avoid taking tetracycline/ ACHROMYCIN, SUMYCIN with dairy products, antacids and vitamins containing iron because these can interfere with the medication.s effectiveness. NITROIMIDAZOLE An example is: metronidazole / FLAGYL Interaction Alcohol: Avoid drinking alcohol or using medications that contain alcohol or eating foods prepared with alcohol while you are taking metronidazole and for at least three days after you finish the medication. Alcohol may cause nausea, abdominal cramps, vomiting, headaches, and flushing. ANTIFUNGALS Some examples are: fluconazole / DIFLUCAN griseofulvin / GRIFULVIN ketoconazole / NIZORAL itraconazole / SPORANOX Interaction Food: It is important to avoid taking these medications with dairy products (milk, cheeses, yogurt, ice cream), or antacids. Alcohol: Avoid drinking alcohol, using medications that contain alcohol, or eating foods prepared with alcohol while you are taking ketoconazole/NIZORAL and for at least three days after you finish the medication. Alcohol may cause nausea, abdominal cramps, vomiting, headaches and flushing. MOOD DISORDERS Depression, Emotional, and Anxiety Disorders Depression, panic disorder and anxiety are a few examples of mood disorders -- complex medical conditions with varying degrees of severity. When using medications to treat mood disorders it is important to follow your doctor.s instructions. Remember to take your dose as directed even if you are feeling better, and do not stop unless you consult your doctor. In some cases it may take several weeks to see an improvement in symptoms. MONOAMINE OXIDASE (MAO) INHIBITORS Some examples are: phenelzine/NARDIL tranylcypromine/PARNATE Interactions MAO Inhibitors have many dietary restrictions, and people taking them need to follow the dietary guidelines and physician.s instructions very carefully. A rapid, potentially fatal increase in blood pressure can occur if foods or alcoholic beverages containing tyramine are consumed while taking MAO Inhibitors. Alcohol: Do not drink beer, red wine, other alcoholic beverages, non-alcoholic and reduced alcohol-beer and red-wine products. Food: Foods high in tyramine that should be avoided include: . American processed, cheddar, blue, brie, mozzarella and Parmesan cheese; yogurt, sour cream. . Beef or chicken liver; cured meats such as sausage and salami; game meat; caviar; dried fish. . Avocados, bananas, yeast extracts, raisins, sauerkraut, soy sauce, miso soup. . Broad (fava) beans, ginseng, caffeine-containing products (colas, chocolate, coffee and tea). ANTI-ANXIETY DRUGS Some examples are: lorazepam/ATIVAN diazepam/VALIUM alprazolam/XANAX Interactions Alcohol: May impair mental and motor performance (e.g., driving, operating machinery). Caffeine: May cause excitability, nervousness, and hyperactivity and lessen the anti-anxiety effects of the drugs. ANTIDEPRESSANT DRUGS Some examples are: paroxetine/PAXIL sertraline/ZOLOFT fluoxetine/PROZAC Interactions Alcohol: Although alcohol may not significantly interact with these drugs to affect mental or motor skills, people who are depressed should not drink alcohol. Food: These medications can be taken with or without food. STOMACH CONDITIONS Conditions like acid reflux, heartburn, acid indigestion, sour stomach, and gas are very common ailments. The goal of treatment is to relieve pain, promote healing and prevent the irritation from returning. This is achieved by either reducing the acid the body creates or protecting the stomach from the acid. Lifestyle and dietary habits can play a large role in the symptoms of these conditions. For example, smoking cigarettes and consuming products that contain caffeine may make symptoms return. HISTAMINE BLOCKERS Some examples are: cimetidine / TAGAMET or TAGAMET HB famotidine / PEPCID or PEPCID AC ranitidine / ZANTAC or ZANTAC 75 nizatadine / AXID OR AXID AR Interactions Alcohol: Avoid alcohol while taking these products. Alcohol may irritate the stomach and make it more difficult for the stomach to heal. Food: Can be taken with or without regard to meals. Caffeine: Caffeine products (e.g., cola, chocolate, tea and coffee) may irritate the stomach. DRUG-TO-DRUG INTERACTIONS Not only can drugs interact with food and alcohol, they can also interact with each other. Some drugs are given together on purpose for an added effect, like codeine and acetaminophen for pain relief. But other drug-to-drug interactions may be unintended and harmful. Prescription drugs can interact with each other or with over-the-counter (OTC) drugs, such as acetaminophen, aspirin, and cold medicine. Likewise, OTC drugs can interact with each other. Sometimes the effect of one drug may be increased or decreased. For example, tricyclic antidepressants such as amitriptyline (ELAVIL), or nortriptyline (PAMELOR) can decrease the ability of clonidine (CATAPRES) to lower blood pressure. In other cases, the effects of a drug can increase the risk of serious side effects. For example, some antifungal medications such as itraconazole (SPORANOX) and ketoconazole (NIZORAL) can interfere with the way some cholesterol-lowering medications are broken down by the body. This can increase the risk of a serious side effect. Doctors can often prescribe other medications to reduce the risk of drug-drug interactions. For example, two cholesterollowering drugs.pravastatin(PRAVACHOL) and fluvastatin (LESCOL), are less likely to interact with antifungal medications. Be sure to tell your doctor about all medications. prescription and OTC. that you are taking. This brochure was produced in cooperation with the U.S. Food and Drug Administration. National Consumers League 1701 K Street, NW, Suite 1200 Washington, DC 20006 202-835-3323 Fax: 202-835-0747 www.nclnet.org FOOD AND DRUG INTERACTIONS The following list describes potential interactions that may occur between certain medications and foods. To find the your medication by drug class see list below. Drug Class: ACE INHIBITORSMedications: Benazepril (Lotensin) Captopril (Capoten) Enalapril (Vasotec) Fosinopril (Monopril) Lisinopril (Zestril, Prinivil) Quinapril (Accupril) Trandolapril (Mavik) Ramipril (Altace) Moexipril (Univasc) Perindopril (Aceon)Potential Interactions: Can increase the amount of potassium in the body. Limited foods high in potassium such as avocado, banana, cantaloupe, grapefruit, honeydew melon, sweet potatoes, orange, kiwi, mango, nectarines, prunes, and raisins. Report any signs of high potassium, including confusion, irregular heartbeat, heaviness of legs, weakness, or shortness of breath.Drug Class: ANALGESICS Medications: Narcotics: Tylenol with codeine Lortab VicodinPotential Interactions: May cause drowsiness, so avoid alcohol and do not drive or perform tasks requiring concentration. Take with food to decrease stomach upset.Aspirin Derivatives: Aspirin (Anacin, Ascriptin)Relief of mild to moderate pain. Aspirin has a mild anticoagulant (blood thinning) effect, so avoid gingko biloba. To ensure no stomach upset, take with food. Avoid excessive alcohol as this may aggravate stomach irritation. Nonsteroidal anti-inflammatory drugs (NSAIDs): Ibuprofen (Motrin, Advil) Indomethacin (Indocin) Naproxen (Naprosyn, Anaprox) Diclofenac (Voltaren) Sulindac (Clinoril) Nabumetone (Relafen) Etodolac (Lodine)Used to relieve pain, inflammation, swelling, and stiffness caused by certain types of arthritis, injuries, and other medical conditions. Should be taken with food to reduce stomach upset. Report to physician any indigestion, stomach pain, diarrhea, or black or bloody stools. May cause drowsiness in some people. Can increase blood pressure in people with high blood pressure. Drug Class: ANTACIDS Medications: Mylanta Maalox Di-Gel Tums Rolaids RiopanPotential Interactions: Take on empty stomach -- before meals or 30-60 minutes after meals -- for the greatest effect. Do not take with other medications (allow at least one hour between doses) since antacids bind some drugs and reduce their effectiveness.Drug Class: ANTIBIOTICS Medications: Amoxicillin/clavulanate (Augmentin)Potential Interactions: Taking with food decreases the stomach upset, which occurs in some individuals. May also cause diarrhea or rash.Azithromycin (Zithromycin, Z-pack) Ciprofloxacin (Cipro)Try to take capsule on empty stomach (1 hour before or two hours after meals) because food reduces absorption by 50%. Tablet may be taken with meals to decrease stomach upset. Do not take with antacids. Dicloxacillin (Dycill, Pathocil) May be taken with or without food and with full glass of water. However, avoid taking with foods high in calcium such as milk, yogurt, or cheese. Do not take with laxatives, oral multivitamins, or mineral supplements. Doxycycline (Vibra-Tabs, Vibramycin) Take on empty stomach (at least one hour before or two hours after meals). May cause stomach upset, diarrhea, or rash. Erythromycin (E-mycin) Take with food to decrease stomach upset. Avoid the following products at least one hour before and two hours after taking your medication: dairy products, antacids, excessive alcohol, and multivitamins as these may decrease absorption. Avoid excessive sun exposure. Isoniazid (Nydrazid)Take with food to decrease stomach upset. Metronidazole (Flagyl) Should be taken one hour before or two hours after meals or on an empty stomach. Avoid alcohol due to increased risk of liver damage. Minocycline (Mincoin) May take on empty stomach. Take with food if stomach upset occurs. Avoid alcohol during therapy and for two days after therapy completed. May cause metallic taste in mouth and/or dark or reddish-brown discoloration of urine. Nitrofurantoin (Macrodantin, Macrobid)Do not take within 2 hours of iron-containing products. Take with food to increase absorption and decreased stomach upset. May discolor urine to a dark yellow or brown color. Avoid alcohol. Penicillin (Veetids) Take on empty stomach one hour before or two hours after meals. Report allergic symptoms -- including rash, itching, breathing difficulty, swelling of lips or tongue. Tetracycline Take with a full glass of water on empty stomach one hour before or two hours after meals. Avoid taking within 2 hours of dairy products (milk, yogurt, cheese), antacids, laxatives, or iron products. Avoid excessive sun exposure. Trimethoprim/sulfamethoxazole (Septra, Bactrim)Take with full glass of water on an empty stomach (1 hour before or two hours after meals). Avoid excessive sun exposure. Drug Class: ANTICONVULSANTS Medications: Phenytoin (Dilantin) PhenobarbitalPotential Interactions: Take with food. Can cause folic acid deficiency and decreased calcium levels. Avoid excessive alcohol.Drug Class: ANTIDEPRESSANTS Medications: Tricyclics: Amitriptyline (Elavil) Imipramine (Tofranil) Clomipramine (Anafranil) Nortriptyline (Pamelor)Potential Interactions: Avoid alcohol, grapefruit juice, Valerian, St. John's Wort, and Kava KavaSSRIs: Paroxetine (Paxil) Fluoxetine (Prozac) Sertraline (Zoloft) Citalopram (Celexa) Fluvoxamine (Luvox)Paxil, Luvox, Prozac, and Celexa may be taken with or without food. Food increases absorption of Zoloft, so you should take Zoloft consistently (either always with food or always on empty stomach) to reduce variations in absorption. Avoid alcohol, grapefruit juice, Valerian, St. John's Wort, and Kava Kava. Drug Class: BENZODIAZEPINES Medications: Alprazolam (Xanax) Lorazepam (Ativan) Temazepam (Restoril) Triazolam (Halcion) Diazepam (Valium) Clonazepam (Klonopin) Chlordiazepoxide (Librium) Flurazepam (Dalmane)Potential Interactions: Avoid alcohol, grapefruit juice, Valerian, St. John's Wort, Kava Kava.Drug Class: DIURETICS  Medications: Hydrochlorothiazide HCTZ (Diural) Hydrochlorothiazide and Triamterene (Diazide, Maxzide)Potential Interactions: Used to reduce blood pressure and increase water excretion. Take before 6:00 PM to decreased frequency of urination at night. May be taken with food. May be associated with low levels of sodium or potassium. Report any signs of confusion, weakness, muscle cramps. Spironolactone (Aldactone, Aldactazide) Triamterene (Dyrenium)Used to reduce blood pressure and increase water excretion. Take before 6:00 PM to decreased frequency of urination at night. May be associated with elevated levels of potassium. Avoid excessive consumption of foods high in potassium such as avocado, banana, cantaloupe, grapefruit, honeydew melon, sweet potatoes, orange, kiwi, mango, nectarines, prunes, and raisins. Drug Class: DIABETIC MEDICATIONS These drugs lower blood sugar and can sometimes lower it more than is desirable. Low blood sugar is called hypoglycemia and is manifested by sweating, hunger, fast heart rate, confusion, chills, nausea and vomiting, and headache that won't go away. Usually, orange juice, glucose tablets, or other ready sources of sugar can be taken. Medications: Glyburide (Diabeta, Micronase, Glynase) Potential Interactions: Take with breakfast or the first meal of the day  Glipizide (Glucotrol, Glucotrol XL) Take immediate release tablets (Glucotrol) 30 minutes before a meal. Do not break, crush, or to extended-release tablets (Glucotrol XL). Swallow them whole. You may notice a tablet in your stool. There is nothing to worry about because the drug has been adsorbed from the tablet shell.  Metformin (Glucophage) Take with morning and/or evening meals to avoid stomach upset. Notify your physician if signs of lactic acidosis appear: unusual muscle or stomach pain, slow or unsteady heartbeat, feeling week, tired, dizzy, or cold. Acarbose (Precose)Delays absorption of carbohydrates. Take at the start of your main meals (with the first bite). OTHER MEDICATIONS  Alendronate (Fosamax) Risidronate(Actonel) Take on an empty stomach at least two hours before any food. Avoid alcohol, caffeine, dairy products, orange juice, and antacids within 2 hours of taking a dose. Do NOT lie down for at least 30 minutes after taking the dose. Take with PLAIN WATER -- no fruit juices, colas, milk, or coffee.  Allopurinol (Zyloprim, Aloprim) Avoid foods high in purines, which include spinach, legumes, poultry, sardines, kale, and organ meats such as liver and kidney. Excess vitamin C should be avoided to decrease the possibility of kidney stone formation. Maintain adequate fluid intake.  Digoxin (Lanoxin)Do not take large amounts of bran fiber, which can decrease absorption. Maintain adequate amounts of potassium in diet. Foods high in potassium include avocado, banana, cantaloupe, grapefruit, honeydew melon, sweet potatoes, orange, kiwi, mango, nectarines, prunes, and raisins. Theophylline (Theo-Dur, Theo-24, Slo-bid)Avoid excessive intake of caffeine. Should be taken with water, 1 hour before or two hours after meals.  Warfarin (Coumadin) Take at a regular times daily as directed. Do not eat excessive amounts of food high in the vitamin K. These foods include broccoli, Brussels sprouts, cabbage, cauliflower, spinach, green onions, kale, collard greens, mustard greens, Swiss chard, seaweed, and liver. Avoid excessive alcohol intake. Report any signs of bruising or bleeding or any dark stools.  GRAPEFRUIT JUICE INTERACTIONS Grapefruit juice can increase the quantities of some medications in your body, leading to adverse effects. AVOID GRAPEFRUIT JUICE IF YOU TAKE THE FOLLOWING MEDICATIONS, unless otherwise instructed.Amiodarone (Cordarone) Alprazolam (Xanax) Diazepam (Valium) Triazolam (Halcion) Buspirone (BuSpar) Amlodipine (Norvasc) Diltiazem (Cardizem) Felodipine (Plendil) Nicardipine (Cardene) Nifedipine (Procardia, Adalat) Verapamil (Calan, Verelan)Carbamazepine (Tegretol) Carvedilol (Coreg) Cyclosporine (Neoral, Sandimmune) Fexofenadine (Allegra) Atorvastatin (Lipitor) Lovastatin (Mevacor) Simvastatin (Zocor) Itraconazole (Sporanox) Losartan (Cozaar) Quinidine Sertraline (Zoloft) Tacrolimus (Prograf) *This list was compiled by the Pharmacy Department at Scripps Hospital. Inside this flyer is a list of some common medications. Following each medication is a number(s) that indicates a specific interaction. These numbers corresponds to the following drug/food cautions: December 2003 Approved by PFEC 12/03 This listing is meant only as a guide. Information about medications is constantly changing so new and updated material will be made available on a time-to-time basis. Please consult with your health clinician when taking any medication. 12/03  +, rs  /..i1ûãth^^h QCJOJQJh QCJOJQJ^Jh Q5CJ\aJh Q5CJ\aJh Q5B*CJ\aJphh QOJQJ^Jh QOJQJh Q56CJOJQJ\]jh QU#h Q5@CJOJQJ\]aJh Q5CJ(aJ(h Q56>*CJ4aJ4 h Q>*CJ$ h Q6 h QCJ(h Q  +,  % |  [ "  & F-DM gd Qgd Qgd Q$a$gd Q$a$gd Q$a$gd Q" T = z ,L<`D\ r & F-DM gd Q"#NO)   7$8$H$gd Qgd Qgd Qgd Q & F-DM gd Q  /Gz ;l,\+e#k]kgd Qgd Q 7$8$H$gd Q#NG 9k6e!N Ygd Q G u 5!h!!!!!"R"~"""#D#n### $7$c$$$$%gd Q%:%e%%%%&I&t&&&&!'O'z'''(-(](((():)d))))  P , gd Qgd Q)*?*g****+=+n++++,B,m,,,,-H-p---.6.i..  gd Qgd Q , gd Q.../H/p///0)0W00001?1g1h1i1j1v111111 7$8$H$gd Q 7$8$@&H$gd Qgd Q , gd Qi1j1v11111888Z:[:i:e;q;h<j<w<x<|<ɲɠydR@2ydydh QB* OJQJ^Jph #h QB* CJOJQJ^JaJph #h QB* CJOJQJ^JaJph )h Q5B* CJOJQJ\^JaJph )h Q5B* CJ$OJQJ\^JaJ$ph #h QB* CJOJQJ^JaJph8"#h QB*CJ>OJQJ^JaJ>ph,jh QB* CJ`OJQJU^JaJ`ph #h QB* CJ`OJQJ^JaJ`ph #h QB* CJHOJQJ^JaJph #h QB* CJOJQJ^JaJph 11'2U22223<3l33334C4q4444#5M5555616[666 7$8$H$gd Q666 767g7777&8U8888889G9z999:6:Z:i:|::: 7$8$@&H$gd Q 7$8$H$gd Q::::;;';=;Q;e;q;;;;<*<R<h<i<|<<<<<<=C=g= 7$8$@&H$gd Q 7$8$H$gd Q|<}<<<<<<c>d>f>h>q>r>u>w>>>>>>>H?T?#A$A3AWBcBBBBBBeEqEFF%F&F5FGGKKKKKMMMNNNɻɻɻɻɦɻɦɅh QB* CJaJph8")h Q5B* CJOJQJ\^JaJph )h Q5B* CJ$OJQJ\^JaJ$ph h QB* OJQJ^Jph #h QB* CJOJQJ^JaJph8"#h QB* CJOJQJ^JaJph #h QB* CJOJQJ^JaJph 4g==== >P>c>>>>>>?#?5?H?T????@C@r@@@@#A3A 7$8$@&H$gd Q 7$8$H$gd Q3AeAAAAA BB>BWBcBBBBB C8CfCCCC'DWDDDDDD 7$8$H$gd Q 7$8$@&H$gd QDE"E5EUEeEqEEEEFF%F5FdFFFF GG@GVGwGGGGGG 7$8$@&H$gd Q 7$8$H$gd QG-HUHHHH I=IlIIII JFJwJJJKKGKxKKKKK L9LjL 7$8$@&H$gd Q 7$8$H$gd QjLLLLMFMtMMMMM NON}NNNNNNOO.O:OjOOOO!P 7$8$@&H$gd Q 7$8$H$gd QNN.O:OOOP P(P*PnQoQsQtQ|QbRnRRRRSS3T4T?T@TJTKTQTXTbTBUOUFWKWLWOWXWYWcWvWwWWW;YGYZZZoZ|Z\\ӝ)h Q5B* CJ$OJQJ\^JaJ$ph #h QB* CJOJQJ^JaJph #h QB* CJOJQJ^JaJph #h QB* CJOJQJ^JaJph h QB* OJQJ^Jph #h QB* CJOJQJ^JaJph8"h QB* CJaJph8"4!PRP}PPPQ6QcQnQ|QQQRR)R>RRRbRnRRRRRS3SFSdSoS 7$8$@&H$gd Q 7$8$H$gd QoSSSSS T3TQTbTTTTTTUU0UBUOUyUUUV1VbVVVV 7$8$@&H$gd Q 7$8$H$gd QVWFWcWWWWXDXuXXXXXXYY)Y;YGYpYYYYZZAZNZ 7$8$@&H$gd Q 7$8$H$gd QNZ]ZoZ|ZZZ[4[f[[[[\\\.\^\\\\\]J]t]]]]!^ 7$8$@&H$gd Q 7$8$H$gd Q\\\"\#\.\^^^^^9_E____ ``aaabbccccc#d$d0dqd}dddeeeqefffff hhhhh8j:j>j?jHjuj(l)l2l3lƴƴƴƴƴƴƴƴƴꦴ)h Q5B* CJ$OJQJ\^JaJ$ph h QB* OJQJ^Jph #h QB* CJOJQJ^JaJph8"#h QB* CJOJQJ^JaJph #h QB* CJOJQJ^JaJph )h Q5B* CJOJQJ\^JaJph 9!^F^S^^^^^^^^_9_E_v_______ ``B`s````'a 7$8$@&H$gd Q 7$8$H$gd Q'a;avaaaaab.bCbUbhbbbbbcc#cpOp\pppppq&q;qNq_qqqq 7$8$@&H$gd Q 7$8$H$gd Qqqqqr/r\rjrkr~rrrs2sasssstHtsttttttu(u 7$8$@&H$gd Q 7$8$H$gd Q(uRuuuuuvCvDv^vvvvw>wjwwwwx%xMx|xxxy;yjy 7$8$@&H$gd Q 7$8$H$gd QjyyyyzHz]zzzzz({Y{{{{||:|O|n|}|~||||||| 7$8$H$gd Q||||||||||||||}Q}}$Ifgd Q $@&a$gd Q 7$8$H$gd Q|||Q}u}}}}}}}}}}}}}}}~~~~%~&~<~=~P~Q~e~f~{~|~}~~~~~(*+78:Dcdlmn*+<=HIJ01_`st{h Q5CJ\aJ h Q5\ h QH*o(h QCJaJh Q5CJ\aJo(h Q5\o( h Qo(h Qh Q5CJ$\aJ$o(G}}}}}}}}~)~@~S~i~xkkkkkkkkkk $If[$\$ $$Ifa$}kd$$Ifll*m ` 062344 labp i~~~~*E?$IfkdL$$Ifl0l*   ``062344 labp$If $$Ifa$ $If[$\$*+8:EG]enqddddddqdd $If[$\$$$If[$\$a$}kd1$$Ifll*m  062344 labp +-K0aTTTN$If $If[$\$kd$$Ifl0l*   062344 labp01`b~̂aTTTTTTTT $If[$\$kd$$Ifl0l*   062344 labp {|ɂʂނ߂ ̈́΄&134@Aefgh123#$(+,0‰Élj֊h Q5\o(h Q5CJ\aJ h Q5\h QCJaJh Q h Qo( h QH*o(Q Nkd$$Ifl! 0l*   062344 labp$If $If[$\$΄ք݄qddddddqd $If[$\$$$If[$\$a$}kd$$Ifll*m ` 062344 labp 3a[$Ifkdp$$Ifl0l*   ``062344 labp34AChqqaqqad$If[$\$$$If[$\$a$}kd[$$Ifll*m  062344 labp +4aTTTTN$If $If[$\$kd$$Ifl0l*   062344 labp&)aTTNH$If$If $If[$\$kd$$Ifl0l*   062344 labp.1aTTNH$If$If $If[$\$kd$$Ifl0l*   062344 labpʼnȉ֊aTTNH$If$If $If[$\$kd$$Ifl0l*   062344 labp֊׊aQH d$Ifd$If[$\$kd$$Ifl0l*   062344 labp֊׊'(/04ˋ̋ԋՋًΌόی܌Ímnef:IKLXYpq'689EFHSijh Q5\o(h Q5CJ\aJ h Q5\h Q h QH*o( h Qo(h QCJaJQ(25aTTNH$If$If $If[$\$kd$$Ifl0l*   062344 labp̋׋ڋaTTNH$If$If $If[$\$kd$$Ifl0l*   062344 labpόaTTN$If $If[$\$kd$$Ifl0l*   062344 labpčmaTTNH$If$If $If[$\$kdl$$Ifl0l*   062344 labpmn|ea[[$IfkdW$$Ifl0l*   062344 labpefaTTTTTT $If[$\$kdB$$Ifl'0l*   062344 labpKa[$Ifkd-$$Ifl0l*   062344 labpKLY[gsqqdddqqd $If[$\$$$If[$\$a$}kd$$Ifl l*m ` 062344 labp 8a[$Ifkd$$Ifl0l*   ``062344 labp89FHTlΑБuhhhhhXuud$If[$\$ $If[$\$$$If[$\$a$zkd$$Ifll*m  062344 lap ͑Α#$78LMabvwēœǓȓɓ  34IJ^_qrԔՔ!"#OXZ[klmʕ˕͕̕h Q5CJ\aJ h Q5\h QCJaJh Q5\o(h Q h Qo( h QH*o(QБґ$&>11 $If[$\$kd$$Ifl0l*   062344 labp$d$If[$\$a$$$If[$\$a$&:OdyœƓǓȓ $If[$\$ ȓɓa[$Ifkdt$$Ifl 0l*   062344 labp "6LatՔuhhhhhhhhhu $If[$\$$$If[$\$a$zkdm$$Ifll*m ` 062344 lap Քהٔ۔"#ZTN$Ifkd,$$Ifl 0l*   ``062344 labp $If[$\$Z[mp͕qqdddTK $$Ifa$d$If[$\$ $If[$\$$$If[$\$a$}kd$$Ifll*m  062344 labp  -9XKKKKKK $If[$\$kd$$Ifl0l*   062344 labp d$If6789̘56BCDXYdenoqrؚٚ&')}~Ýǝ h Q5CJ\aJo(h Q5\o(h Q5CJ\aJ h Q5\h QCJaJh Q h Qo( h QH*o(L9TN$Ifkd$$Ifl 0l*   062344 labp $If[$\$5{$If}kd$$Ifll*m ` 062344 labp 56DPrxkkxe$If $If[$\$ $$Ifa$}kdY$$Ifll*m ` 062344 labp šΚaTTTTN$If $If[$\$kd$$Ifl0l*   ``062344 labp*aTTTN$If $If[$\$kd$$Ifl0l*   ``062344 labp~aTTN$If $If[$\$kd$$Ifl0l*   ``062344 labp~aX $$Ifa$kd$$Ifl0l*   ``062344 labpŝȝtttttn$If $If[$\$}kd$$Ifll*m  062344 labp aTTTTTN$If $If[$\$kd_$$Ifl0l*   062344 labp+,-HIUV_`ijstuijlmnopVWXmnpqԤդ/089KLUVWXopqrץإh Q5CJ\aJo(h QCJaJh Q h Qo( h QH*o(W#.HaTTTTN$If $If[$\$kdD$$Ifl0l*   062344 labpHIVvaTD; d$Ifd$If[$\$ $If[$\$kd)$$Ifl0l*   062344 labpjkaTTTTTNN$If $If[$\$kd$$Ifl0l*   062344 labpklmnp[VF$$If[$\$a$gd Qkd$$Ifl 0l*   062344 labp$IfWt $If[$\$}kd$$Ifll*m ` 062344 labp WXqפ;tttttttttt $If[$\$}kd$$Ifll*m ` 062344 labp ;Xr¥ڥ1;Pfg $If[$\$d$If[$\$./MNcdfghyzͿh QOJQJh QCJOJQJ^JaJh QOJQJ^JaJh QCJOJQJ h Q6h QCJaJh Q h Qo( h QH*o(ghyzaUPNINDgd Qgd Qgd Q [$\$gd QkdJ$$Ifl0l*   ``062344 labpgd Qgd Qgd Q,/R / =!"# $% ,/R / =!"# $% ,/R / =!"# $% ,/R / =!"# $% ,1h/ =!"#$% n-ӛH;iOg(HPNG  IHDRvgAMA|Q pHYs.#.#x?v,IDATxu{o,@P a *FJA9JD)JYTt”dP%J\1Ȗ` RR,v SV;e8E8o۝Gabvׯ{z>]@:3wFFNjy6^d5 /Z>"#ZQwpZ'r߄ocD.p h5ƈy6>$ӹHV4;?>d"sH|cC! Gؐޣ._FDK#";GD%ҭi6i !u@}S1!W{.gtN2$},bڸ&lq^nlHgNx*]}~qLH VHلAhHn qo##W{un6u|HuC痌 SSӹ&DŽ dD#OǨ2 q";nȑځApsW5Džr'ƃdNyH*DkVB6FUBKt1! cë*LzǃvPr oң wDž\[ܫ|,GErߍ{! 0#".oփG<\ k{Z%UpDNw|+mpuѐ·͟_9i4deSfuraeѐ -pDf;i4dflۊ6ѐNlOf7FB#!r2wya4>pDT$rρgڛF){U$NWyGBFqE.⟪Hs_ѝnua|H_;57"n-R<T=FBCdq!!|awNn%ZO ^=cWQf? ]J7ED+LW— lV%x}p_wHGUnk.E*ףrCcߤ2u!kT.ʿ{1<H<TxTj<(ȞtB2@["TioOX\\/&T$anipbSO;O[FGF&3{GL'UI[ Sz~@t-'Oݛh\=#|)9/&Uެ27l)mDž.H/kёKWmʳy{9GC}dBy"z6iGGjS6;eH{t Y1#f@KOdz/U B84M=JjŹr U imw|$yWWT '6Aڀ-8 a|CH ֪kX0$Zn !1m~>79ޟb7Mcy+/"=D63feSq%{Td$#˖hqUe ѐ@eӞdSKQU.g3ҲD]*<2iP3,ڤ{Mԥ|2ՆU=P #DNCaT3H.;0_mH^@fAm7Ouu˜g6E . dIC?itGB..\IdyPֈ^[9{h#BhgZLJq"Zn9#T8W]u˶sZ6gD@d+tmp$ I-i݆HT(T\2lvٌaۦD'ZB#"/D' &yH| fP˦;5G@lgN'->R]`ᗸ'D J/[{:vA\6ekν* kO MԸUk4|gt7>?e0.^Dŷ _ůdeFkg [.CEEjZe!#SaW) a3^7:MwSpHWi*Kbt7>^6} 9* ji)vO/=E #XgUjט@tJw8wiOO Oyy/hW\0!;!k*"s` yʶ RrN2!Ei5qOʾha*`LGVSɊ$cG+CfRH6,9ArG&~2}'N8,nZBmw'9Q=)m;A\ͷ++\,T r7Gz!CS.m.(,1WM^k&.$oѱ(GiafׂLghvh%X(g~ԧI KW.MY[B;_ړ[rWrNȗx* :1XY|qY"v"–YrrS ?XXrY_I  TV!qv cKUJDOY6൫ÐvS ןrWP!3 V H\=JŠa#k_s̑De ư։W;J / -S F&u/=H?ev ?2D%Ez7 %RwTWfLӿt3dEJ[QT Gz JڐO&u shՙId5J] QкġI +*+*imk}J J\P+SjCUC\)&+%dDYVpE% swF8\Rpw6AfZ}({e~ݸJ1TŪJ2C*yaDaDD-!'պ U=y b:\)&YWQYs*dϪƐ5o5/I}*US !qpuUA$+G5rUTʕ ^aFSOwsua^2(Gzfc<.Z|(2J0ɓ9wz-WCӰ**9d&WU2 52 XZ.1rH.@χ#!swPunV3jS0%#`&IU%< N~Y3/,FD :S+S9+j2!d{}HU[-ȶz]&FZ|>Tk~Zp׌09fȕ㾫 nc0t=kJkzo_F%A)HT97 "&dNUn<3Z}\|נZhVVܠg5k/vÎ'ե7j (8tպd\nT!s\\u}õd_=+(EV-;WF9%̚(xJLoUyl3v/U/h"^=i lHO_rqDeV #r". +/XҵԾ3@%Z"CtFysę?Y^&UY72 !ř>hJT$]6m޼{qox.m3ʑejjU6D29PZ)MS{^CQ`2@F ꮘaMv)DV'PPYː7}qgy]N1Eɣj9p\L7֕IMI=F◙L꒝`̩ ~b |2LEe)«GI|l)_$eR75lho{q3QU~25rM/QBI!\Fo$l6k )ι ֤?X|{0gR^LjL(tΕ$clZa:Cd>KWJiTNZfDҧ#F6"=uP&Da62ڇ$7 =yDq>sފ} FΙvCzZ7R\t 2K6e d-O`3]K뒝*/g׺G6M.˯`]bڵZj 2uzG`nO!A#QI!* i1!{7#rA8ܩgn^ A ]w\<񥿌@g,U qVPe'ty}ˆlǾu~-״.!KyB9y#TR+i.8C<9Oފ^dFۖ{ԓ:a/WT m%xW<@^F $/[$1Q2iS RY|)K.r7 #$n Is*򖞤W9xѝ=0 t `J a"̚TR|oq ,'%Vc.v|63V})Uu e]/k N5tJ {fk#!fwS"/ҀȂ_Ҭ஽ ԈX ~h݋W`.Ek$nrm8dLU8pXC1_hߕxwccS MUr||"jyd8FT%FO yɴI`2ݜSԻD\Bdvt;݄#i**I : 32Km;Z9Ԋ|6>eHW)c"܌@ ɠ~/2 -.Hp׾1'rMnh$Hl@.H13f%n$CN UJϬZ?,FT(ଽOsul[x?svX a04(WTxc1_AKއ5PGˑXۉ Q0X8L8$N s*aj#յX@|=ge]YI]@*ҩr759xf&S)u_I[?/O)9b Sgur wKF|ű0RtYJ| W5A$/_H˫B~V tZ6HbPU ^S]24fwuHy _$/!s*9W 5U$T8j8?qAe>.SW30R7DkX >w<+my@Դ ~SnѪa_ I{  C1mu/uY Kg:L+L L Gev @G}<+l(HEgRr }uTljoseb@e nu Z:3gfǢ>Ʃ"Cp3$A|s-l:y j(*Mu>v.#1 =2 )HAjƍ&S {Y4`MM u#+|U2ΨPCd˖HE%x7(h55d6G*9:]| =DiԏlU=7k XQT+ WZ"* h.JpE,[ d ̠ ~T A5{W٣|U\TU:`rqR=!(*n[P WhVHz&󠣞HUg,7އ]L@ĨMgu`+BU~C~?2xoLIG{q|?F*q>}VΊ ,)|=ۂ є?dtBHܾ׍J :a,ւW1g6NB]BDYizIG.Wۀ\.䢓3cH HsTd ʱo\P+F[>0J݂s*Wr*=v~H`x!V-q]T阸^aOލ$ŮUz&vr-R{XC]F]4*'UaB;BdEjUFZ$ET)Wt^}9jDejSQUrdobqB߅.,=䐬#93 x^A1j䖴az[tbIk`n6y5] *d]  -]SC,B3"eǎHJD UJ*⡰_eTCG/|)`dW/~?HYvRY R=4 HN8*>5d`]l.e'yiT]8B^%_ф_O̝xAUːq-QP[~3ZUMD%*8Oz{-yaVSSou.qyl?Kn@OJE,L!~"/Rd};;dJ\!NeۏvfbMeHc {CAe`̄p^o6cgI ER0K~bKo9bfk26omj]è Cz^ZΌ)N\tZDbUvR\6K3BkXƜV$Uj5"P[=8Js\o5dMuVܲBrHN&s-MEDs Rޅ{9*­ɣsȨ&FpOS aޣEv+t-Ay T]00EZD4#>'Pf89ӅJ"(0''3ys-|ly,]O+uS&n},Eʪ|Tf禎TH-H}G)|wvi厼@Ȗ?\R$&|/>eXRD ,{靥HqxGz17wmOr$_XP9!;KTb;B9R=ub wPLJμcQlȎ,);Y}>PλGruBnr\E).cFG="CIENDB``!SY`̼*q=3)Jx|uUOKP-kBqwwww9˥?3d2I&wVpcs] "zO43qzt%_ѯdNXՇg C >^+N7ʔC~<2DIY!CkO 6H[Ivn}Vn6i"NMoIv¹ÝYg V)`wYIS!bRywv8לNXߝ63\f9H4N9礔gg2NԓDQr'W/<pZP|6H$]RC/ɴ.:-+kύ:-5ݪmzQۤW젾۽9݇Z}ZK䆱2Y8f1NkZPvj(W.z,zȉ9/|silϦj<MuJ7i]otF&y6k[?]}IsLE0YXSQl-- }Eо,2 _t=YvU!)jkۭbzruQZ }n% ĚMYD-Юn8~3ޔs2=*n6fi஗J).,INh$z2oi}%rA۱ev:JziWQj ͤӱ+8E;ʹFZ%d-}quZ٢ZØ}ڔ]{9۴U>٬sj^sC甾q.U$4r_3C#86;P0\h]ѵ^zA~RL/:D kcP h$TQW>sZMv:>s:|?o Aoim|xhpڅia7} ujw= О00L}ms3O;QwfkkgpfD&D0Cj?]#eCRG㝴S:Y0ՙCjUPڠ.|hcXhV>knڍI<> Vt00YS=  a}Pb+Unw47\4C r 2VwvEZUkNeLX}g `xgm$HF9#Y:Ao{ҧǪ;Ggәua] ט?|YV[ʀVS*[5i%Jc+.-,6vA["`1EZzJ_ 6GF882Rt"3-/^ ̵R˭^6[$mlò.3tZ;inoUTȹIJL)eA{P_<=f)lK9AO<ӄxP2Nji6^PC˃ #MzpgwܔAi8ݢ֯r@q}){ijrQ%]ޙr>'5#}Q%4"cC>BDylW3lvx?fݟ9|5k[xO'}pFG|o:2{adF EFkt'Ѥhq1W_ɝ`}G?Ct푦K%M44ZiO6љiX`H17k)cX,+B>+*YpŊ pۼ߷~wx$F%VCJy[T*e@5IYp۱/Knw'HJw$pI,wpW':VB>!WB͇Dy$H܂%$[N [] @mH>7m&VR&'M%F-@KVqݭ*Jޭ FOf2M \[ ybM5"Oh4-'+O0&[*+ll_\3y7 %{ܕp {Oy$?Җ˽.ESΗZЛvRm$%} UGfs2k̬O~e[i)`F(Kj =kL7v2[O[ƒC;u ;P_jkXOمl0*cd`%Do9,g/l妝v@y:)Wi`md W>Lާyh^nǀQ`\t23\z?`?nJ({ħt|&Z$!=cZt:H^kþZj֖}F9 2ɇbk~yfJZlhɵy@$,5TbZJ !S&[_=9nt]h;.}&l󲑸k6Q7&]-[ul'ԙ&=|?kV|':kVK/3KmS%)BYƦcm"[gw*-HuK%vHA<R[K l^6y(ؔ:(n] G2U_R.q;4nsrsCu'Ly=0"!Kd,P.W:5cǪ${o)yd!cWDnU=vS.nKz pR 4:J`m]qlh 8yd-Y Ei!V#D]Dz| J {}!O+!eU#>zP95 D)"HCO/#R&qaw,âX^xC$,+*" !H%a5)V8vuHR>IY]xɅŎ bCE/'S48'8/2r"ogM~zrv~d=v_OsTx.iO:9 :S7?W{er.h68 N03g!..9r͜vC1`Ͽz8وbյ;i9 f)R s#ueWlǖWQ,4 "b_)> 1TP@꾲}fLt,gBGiO3vV `/<KbKs^-CYrxD* U)kP_KoH]bv]SvZpnQ* >^Dߏ4urX@pbC$bC`8bC"Cp4 @1hDt" ݄h:HH?`CDdx}"zQHKDFwUDl-"t2%,ug;3<- /|Kx>pϽ+98gATD,^y>GYNC4}O筋4:Ew6g}Bk!7syb-'%ƋsPfQo}=&=CD7GI%:sD)Ϗٹ@b H@]zv`Лq?ָ?kڟKYǮXq;-^Ֆo-gG~n ި;unj=oG$b4ѼDZ]mcuU?lrXwXGjuFTist-ԡT{ d&V:k%0'F]`u8k:njWEh:v_c`W{fwpFxg |oGPPZX>WxѠ n(.$o9tֲT +-v":>JzX6f_T[[5fߜ= a8dӴ ~xU5oOu= z< <]B58χ;@}zNݴM^9w>G˟|DVȌ'2Mk7G2`+gof"-`[M4~0h.-y9o)qc>Z~o/)|r2I:> {-  ,>q2#_6DڐiG0+|xxp\kIbYe dDZV3=Chd_)@ko7xf(U\ċOG&KsZcskZ< & LDl(ޛ*xw_ KߦģS[eW@bA1P=3Q'}SR$ijţ6e~"e^_!XtP"*泇iYz :>Ɯ_vf)KzW'cWv貞D_yx.+NMڽ9kMkBIJGg흖gXvGluql;R[nߺ?>^0H ig5o}';_t?;|s%<#}=$ڳ{i16]iεQq޸`{d^l_?} NxE'ޏ"oSr+_䥆үa ad"'|L>wW-z@yD.<w<SھA~-챁?LN\$pHbpHjwsGIzw"!iE]C= )CQ>d{׶[^.y^IƜyh1Z)Ηdrn_)v_Fg q{¿F^U*u(<rI݇DoNK}wȼqAJpO6܋̹+5c[TN8;Kv1jqJm8gih*YtVtΖ:6 Dz lrFns$ y% gC7aK=lޔuF"Llh%m]ws.)j;&2Hb 8g6 )q>_p;gdOp:sRhj_k}CI_Nr])s,6"~8EjCv#t :[!0ds)}[%HAai,2^vLw\Ϝ?3#4>*Ujзڜ4ks*@~9+>4NoF˦;J脮: Yokg-I+M^+r%6wʼ:$ʟ'dLa*}Ӌ1 g0cz!'S9#ci@D Cp $D#QSFjD QALD'QGaIJE'¢+Iy˾-WV3?x y&!`GqXX V.+XDfHs"x3iY$vV:1֐q!O/SjhV!,sD|"2ڏJD`  ;3S|Aգ!Ϥ#>|ȘYS`UA:d@]fze_vMR&4f_@JND$xa2Rk*z4<ČISb'AOkig, >Z̤Vw:h=6r1bpjKg6wiSg6phPMۢ ZY VU߰z85%Zۙ`" Gp }0wc0v8&iW7ϷsDw=a0s ֚!gN2 =D#Z9M@+SׅE=ȻK~uiG߾q69 $ GXC=:3[Θ1=Y\{-}<Џ3 C<;yvNPT%n( ]ɩ{k9<9&A.@>dӳ8LVp.=&A0"T=Ѹd" / .]3@/cg#`/ V9OGo36ۜz99f޻Ay=q:[4_3}|@;,af53o}FXȸ5+7QM?/~|pfw>ǟϏG|s@\yoۻ秾gP6P+oC.iw9BSr*s8+N%B8%;XBVj&!?֒a[@~9,n!msdg5]?{$#>gb6@<<|%>u $`Ic]$\X ZYKnd_FpcdMsy^FZidAvLim%خJO&(b{X&N˜6L6T~hk/cK[- TReR gb'@nO~Ƕ?$%*c[%`%݄SVWd4+sXdyf,쥤{$8IrۂJR[yМ ɒƃ7J<8 ț0f54V@{L3%s"%m9R:3SsRnA}}0/E]G'̣ 72 YV"j oedj;mȸEr& )?mll%7e9ÜC:=Ρ3#h#)!w}?fxj*KILiLɒj(>&CyJ{urkp{{^|dk #12Xy 2/O',UcO-Po.thɉp<-9Ň;7':z4lԫQ/f,|]zDS\֭۱=@;.^mb1lOyw W4v4Ϛmx+їX)#3%+8ox~Mk~|lgk 9#c: p s02k|[%a|b46U[9Ɣd|qhnIxxMm#{ȬЙẑhy>}N[k~g@]bu}"""%9P U aMqJ#D'ǿ== M=6!x ޳@\s?k,g=~by?WՏ`ِ)#ɐ.!Cq s({=#J!JdWw}<>>{]NwƷƷw(\_xev9]α)h/`߱%=!c'O矑}A)k 3-|f/^@ՎW3rFcA)h%ݤ{-xF۴&'P(KNW\ hYߎ vQC&t:r-$[E>mХsxD>7 nĸvmz͡@8CrF70uj淌{ϰ*Wȉ.+\FK*9\y?ΒOEoɕNqB;I&8l'u\$)BD{w:p zlME fԎu h$}Yh7+ͪ+=.F攍k fRuU#`5xRMT bM5hej;RB.~G>q>7u׿Y?+!|_ Fo- oE}?M3&7kgb "& yo q[gYWEuo;x[!Gʆ>OC`r.UZmX;D]v0ؕq3'kK]M?[e_ݴ<;[EhUG:X{JuFzjՐ*CTe^WgF: , 4=ZU,@C֙[dŻIx"O-d#h%(}N.M u KhwmyjKK Mu6 ڐV:@;ӣZ@k<"u .o( xN]%ײL&|]H =<Xmoy+57ޓT&4Nr*ϡ˵.R:W+ Sli&mUWV/s럚FhlCZ}+л^ Y![A 6NF<[emP؏45Vmd 4:r,|jՍL!},k2/suLsԹ2TWO@~ْAK*9@P@I)+ե<_tuo|Wk[)u"K^]"˩%nupUJ%)5YA5Jѯ n6GPI}>/&s@}yP~cg5SKoVժ[Ux]2qnXXJxғFO _Q3c{^BV"MnO+g=ƆWj;|[ߔL? rdˌHysԟ ,@tͥ̚Uk ~9o4Gi~-Ex.F] JS +RMK2Wh LO c a3s?|n (zG)@\UKb=,I(8rM4FZtޣ(z%TYjqjڠ.uA\_i**|̗8V󣼑<{wB'bhXbIX "ݣZ{VbKV7hߛg>H$J_[l[ |y Zcwñ3"ɈLhh46vn`UBy+\ -@4 mFFQ(NdV$mbU{1ƅ_\ǃ_|$bTF%z*ebecF\J̚R3jjM^4 y$Z % =iAK Zb"'OoC3xߌ֓I8fʹD9M. .ڔ>͝1™NX8kQjeJ-,"z)=,~1K",aZ$ :p?u}L{OtתNk^^)_~eM4bSSj+'H;Pߍy;t-`E8L4\&[Y` FhWvANꀯukK-{&ﴏ@c\o AvYG}#}4'3>[;s,3(WS8=>; ,V.~>1^wgk7 @znH^==n ׁީ`$Y^:XDH9OCo=53ֲ׬fXA m!<29+vS7O Yo@clrX/xēCW"[j}%K",idfRKPZHk/ݬ~2 'm RJ_<cNK 슴Ҟ3=$}0!o2Ɔ)}2.HYmf5$k$3u$69#o,!&mXVIDB?%Ŵמ07̾JJ ?X8Mk4E iKe$$v%g^o9-oŴ`&K |cd߱6Qi :+DBAΦKVho3^ʖIE2SsA߇h"7?\v }_ fƬn m$-SbYVB[vYj:vle+2n Q2, 2e=+re p@A ;/yNZ$E$5nL⪇d_Yo4%(T9 r䯷 .5#9MVrGޣ%o> rO#42jtˠG蓡X % @< f?EMO&wp)o3'ѭs)m/>__S$V=>~uJT616F09C6x[|!pՔrEE&UԴ2RϊIC+M-4bK+/a~ ~39򇅓Kf[2kdL"2 S9RFWP Y%Hk˃ E +/2VCĕi6 o+㬇t47bD7I׽Kν*ӽ% AJѽR=*%nTqH5Uv#CkuI$vh'[h*k.;Ⱦ5_-o͖eĹUİĞġ?Kٳvo|z<O:ѳ:Oo}]4҄_CJԷ=ȋ ,o.w=ٵ-ef*q#DZD[6AOGԱ[HL=4BV@3[YXmͶEȶ9Qx߸F k Oi+fv!fh[C K,=2Y3f;ggiNki=I;ׇ$söOf.6cD+ݔ1+1 2UZٚqFgx{2xTN߬RZy*n'zeNI- (:`,9x0B8ҞW4hm͹ZſK ;<+~d(?ZƮ6XT`õuʡX2oQu5s߆].a3'Йm%'I#"yQV}5̱ nh;[ϵwy]`\'t=Vڥ;nf֫z`ޯE ;&^y(3zGvjǡ7tOA,|"|/k+hFɦh8ԯ:W /#Yglf CS@p]y~E+` xf4B{:xXGBd v"vkD=)ڶ r\>}3ڟd49_><C׻G j(]6k5Ղ6^9CExRx Y G2DR CDw!>4$CƱ~C4(d!||$pִDZՆa,J"Oq֭(,GvEP_F1zoH %Z׬$_xr1>;r a@hy=n #EVCNN:Jk[]x&ˬΆ$ S t1@N<  rMȽ]` tLG tDi4̣oXN\[mBe LMkkt tF0zdmE'u+gc4]O_pt1񓭙Nmt!<<^K]# Oq*՞|U\Ҽv?yJr kU>*_2b}=e/Z|. Y* [fXAj-eWmf9L, 2"0 ,a-}3[f-;csZLV.r4n\eYAo]ѿz0X"8$`\h 12VQ薀Oo2yoa![}ԥ=uo%!wŶ5YZt[N9LA1 O_xud|;V5ZZŧ-e\h(b`]Xz Xzs]ޖy.h%փsBЌ47mB'X5rtB-1{;z-t< ēFF`.XH2b%kznyvnIзd/٩s? ;SrY_ӽE ޷yBr+'B#}:נtÿ~|:o)_Qb7&*E[w3?%GY$=%bB # }"W2#⅁^dƄ~<$~*{H#sQsgwOOg/ԽbK@~_?06t<>!~C`]Q&<?Ep=+_!LD+\h^幌TiM{@q´KM&eNu==.qҸ̞w V-֥*-Q1CZOp+ʂ*ʹ7F6Vh7EfCsľIۓc%jI֔!Z!u.NR}>RթbFi}+L쿛౉Lh@8LrX]b~K8_(މvoG#CoPME7o+/ ]𛉩4dfΜsO'pjgu1#v%zD9 y|O\{o߼g*=9;zPh1&PqwCBn7U6aXe V{m,SOb}9~L4&OYu<;G/*ΎG'&&&ЀjʊʠJ1뒉U.s0, 5 Np!ceJڤ'V)MwƬF><|waj VTۄ3~!s͡w/:0h_%¿ y胀!|T*jaeĔeM=pHw_#|srG K+Ķjrj_vwVnm9[e$D{0CPNG  IHDRTsRGB pHYs+IDATx^?h]Gƣe!V&E/"`jI"uc4!$\v14FFvvY02i@Dl%`HaL :`]\ysd)h|> whѣԔ홙UJ(gh be%1Z ѣg?3i}*`V(7 8H'4Q[jpE G݇)q Otπ5'/_?no/6*g;:qZZz뫵6ݝ>~ l{d>%]?A[spNRGxpnf)GtKeu鏫U` Cvkӧʙvm ß*\qkkjsS2fu6=8MhA[#V._0ccq-XD߷n[$`WV ֑#Zɥ%Í Dg`D4pnLLsຑ Hk_OIԇTU >JZzNVWM$4| "qs| }Nvf7?B`1d @ljm_0D{Vz48^7.xa-Fϟ#!̅Z ɭiǻK~Fq0j.1v>pd>8!(陿O쫩l2rrܧRjmJ3X23hl.@) zF)'H֯<wrU VA-dZ>>Nb S08%SdR jcC%<|܅R+V})|Σ1{/n# [ {Hŋ m M{ \ZnkO;` fϳߦ6H(ʎw6};26qܙf@+ycmJD۵! \`+/UF|_~R#> C}]qbI =>Tv#蜽 h4LM!#儦K+++d: V5f;wȨ FWtKyABJH &а6AfxO ĞZ_;\ K&*Tf̧vl|M(<*FmAŦ|2teu:PQ &?^jrHHQmsp=4V} )%i`J wm|w钶c9+;!]paqq?>R{۴0 vc @'/~`=I,NY=8^iYE r{(>\KhzM."J%D5SS5Mw57q*?IpL,3E/9ysk@*( vj1g򈡪7S`'t:PLpuU:ei3S6uBfrZf@؋Aq3JpT:~m ̂6'\!tI #{ DQϖ3ؽbF?(Ҍ}6x\0ڎ.,VQvǸ +Sq'L䊶,V?s4PU rJbjpj(}j_YYqtϑ[i7VU1hf[ !*t etP57Y8uf#oc Bn\%;E>?8 HR}B~:\H`ǯMNث <13CDx _%2gÂS e40իWYK`w͗6j XQGNm!Fq#`:~$&w̹E`ѝΖf @KQdc% >U\"8TFfA.:K5[^ ۙ Q v֪@ RӻC2-n%'U)|X1e\A=&Y'B|?4jKu׌F<6B M! 2*W^L+T`\]pCcX+9BR!DŠ@-u0ȟOMaK#F_5AM#3wx\5$[.NLc:'yϟ'iLlQp:9z;k E#Z XQ_6{A'Yұ; c RŞOgd ;w$ q̅A A7nj/VN/@kSSAȦOzDѧaZ[E|0G#XevdʯLkATbM6}tX{;QJ+ .j&"pu0何u$lӇ$Al];F P^]ocSKbرNبu v OdcjײM*:!*nK×2+kw'*$Z76fz:&cXEPWH!(5`4 >6m:h`VgS~ZUA.W) b{27j rj*w52ͿL Q ;1Е|  v:'߃/-1M@9_N?Zi,erY0qv…5aIN2fS-*X~֊ 69ŃCv/)ĸ{mkzH@I%'v;SD3DJ-'sQX\^hqêΑ^0ag!TbtRt1g|IK/Gk#aJVm`}Q,Y<Q/,./ 2VG6 Vi$Q3!>z5Jjb C@ :Pl3gx3.?tJS{U~\MI 8~eޤ+潼PNMz:و]FUNj?`Ug[ޔPb}QS0Wf gvޘqC*˳iOĹsl;Jv$׮bft6%619"^$%)Q0rN3AUͧOPNg2AxSM'nNGڨ~-aӃ8v";|,霠' ޺ƗC wk[^ ~ :aTj/h0*#NĽ"n[ahU!Ů ZcҸK2;bWHc^4$燧zMDR~hIENDB`DdY8  3 A?" o8wM?D@= o8wM?/ '/x}xguWX))Rܒw3L܍"D $@p֕֨[z{ܓ7 lW}0d{s˹履Eŏ?*`aQ8bga⫓-X%?''.\GX'~Sf7| ~z~^]QF+!C0|p FuK6:WYbmVW_h!#c~p(zFMqӆP sP1\~,Ї>#F\]]żxzz_2FhGLӉ]dnzxy0'f9`"\'_D/"&~7%o+\giC-<-w8NAa~1ۀfvk [0FK^p  z6^#8?D`8^l |*lD EVû_m90SXh{cF :3xp8C`bSLj^lq}g QהO]W2wW 6Gρ>nxX[ gێn&=axD_2J|oc4gggk/O= TkvЙ,f K~pN 108 C"gx_=3`'/]&xw4(uNM?{т-7[z-ơj]O0%#bĩN^ a>X0:KϺm }@gp+>{5V8)5<*[  Cy_G3{-ۍAa=LJE-pz~"B cZP`sE@%\ m<6 3v7 \OƋ-Ɵ6axWXb# rᮟST=WųAްu NQӠa62i޾}_;q Xm?y錡@}Xl=`.<-=0Hg=BpD$jDdp7"={gCP; y,8GFaj U<<-芋 >;Mz]{#f ϐ+/D&GNŻn[:)WlXQd|z.¸şNp>;.8&"""z,22R,**ǘ[ DPp&1sHMފۃ! +3Q؞OEX|j)*9 =qslg}oM];l_܉OvWӓc^~0^}M F{1VJl+ubY;[>qN60Lh$&&"55rYRRbccb Câa4Dggb0Ke W?|BbuHY No[8gD/5.>oΙAa>SĬG8~Ogc`׏Px@d';޳vW=bSLHW(k3'vcqEމޱy>{pp졡=\NGyy9jjjj*[ذaonnFcc#/_րj,]Z e-A\R,bD R}eOlxDE"2(q;v3d-1|DQr^GL5> Kb3 13u%ӟ/l[2?Gq D{⌨ /Xn*Β-sjXs# 7H+H30yz;N>g,N>ONNFvvp6yAގ}8~8=*8;wb˖-ͨ_ʚ .S|%HNTظdD$8W6/8~L1h %!6ytA mD`dR҅1wE@5\_/uوi!l}xX^،w#=!:MvH?lI~R_'ӿq.x>|`,Fkϖ\OT;4kz9⾷6N:s!%%떖lݺU0~)x㍸#<zH;p 7u,cVkY+_Ye%R~ZZSx<6!P 'E Y)q3!8_^g0z *)X -LL `>؜3pw0փu"j,8Lg%J_z@ۺDYӢ.~pPT6]+:ۏ>|y>=q ;wD[l^u(T/(FFf.RXpc]rSf)F\l3|%}ۙH -y, '5LW [X:z].:+9 t)B/9V"bflFgX䧸{Dj 0?L9Fu553ϼk"͛7c׮]8{99__5{~!5 1p7̕|8D&ଟ8,)i"қ{xg-  uQ:kUd#߆F : я 3s1>`c+e-Zo滣L?m봸w.y9:s+WDGG#<ǟx 2^5/?L!<ܳ8| 뱦y5+py| _|./) yT!ݵ m7e奊*g")91*w5e l ˧"!>و[&l%w$+Vt:;K&d鐚 yk~K߁ σ{"w:x0 00|e!}Ank%Do{Q 9j֣ ^PDxDt"’dELM[D΀nt3N\nF\sk9b:dzzz^^ӧ+>~٧o&>|x ,/4 es;{L,IƱGޓ??Ӹpw8pp`~&T,GIi1rr w+ =S|ԥHHD\A|,)= p;y~@DzK}yHS{36w0ZCE-w^)HztG$׆0/q5 fI~LDG;]|]O.0hވwѴz9M#1{qq1YO馛SO僿=1W[3z^~ Z֫o*yusػo6m*EŅ|!J@rZ,RӲY4&Eϓ×,5 g/K\ݢN}P;_?"2 o O>{oԊ*/G|d$JY[p5 ыl`i9Rc$o-|E<6<i.HhP#Ӄk\$=1aq~NCzq}C?/QE記GEFKzꌱR4?G?9-fg~91'GngOEx%yㅣǎ??b;xpUa`_`W_q=w +*%SNbt[ xFd#rbli-3PR\ xfiy)LV}x,BbQ0= DcV?{gN8G}/N >7d"iikzNZpbtͱߋ٘pњŧ :&QO_5v2)聰D!*&T=BN4c?6ӦO3nnųNsvvvO^go/Tg5~fLN=wFy7r4}O>Xrx|1>ڳ[`\ӦO#> | 'OPkOahHm's@l,X OJAn~җcy?+^T5OL3 <!g B4q:Ȳoo/eJ,>7=iʗG׮/DbCk)!_كw򚞆=usK.Ŋ+DJ-,{O[YYIMcfl۾Ub{|^}n.:/'>Tr7x=ZZc¢gϙ;[?HrÏ<$}:v]3jPQUB$/YP'gUH4! K]_YtZtzQx}?Z@Yjpc.^쏋wZ{~$ Ⱥ1JX&vkq,~h|QfйGMzH2sw<)#Ljlj|x֑#+?!1^og-.6w%~'{d1={DK9:nμq9h@^JZ||-O?}4)}u♏#g3[Er,q'}<%gO745aA**x!`܂FI`rjrs/:ݼtĦ< w"dFaiI5왧1,}w#1ۄP< ĬňO Eܒ;̔ iaHIKBs/Ij3^w[ЅEJnԤ>MK-1!1qw;r ٯzj^wpp_|!;Ψo7J]ZrsN}=\M<_1r._/}J𻥣%E +&LZe; xuٳ>ѱknT*}Iy)fHr`wH[ ׊n'{i&sa>K\g +PP%u:@Gx!,0ꮑy#)V}?}saZyH/ ;y.Z:MO 8K]k|<2>)+JN'ΓB&em!n쑉KF\z>YqbXb$'%y>6uʵie_jkki&o6RΘzYKMKdvbqیrvfp0\xϳNǚOJ,pxu`݆ ū^Qe1+x>g";'_z JTܟiY;' +r`􇳯Q Hpyn0_=z{@ɻuG7^֮kg@9Z:?2MJu_$ =;UNͼi̢J}0y7^/N ƎvljoÆV_+{l/.tVIy2;眳>s QX\^p pBFa"ଟ!Kp,z\L# 2)!2Km>BQPdEd:}xuT|O,9($M?Ǧf+: iYHK'*\.1ywpzrt3GkO1Թ2Ƙ8nr1L>T1»wtnP<{w5ӷw 3>݅-ѴE&9uI}K˒L#5ի3%?ϙ?l ދ/S>B:켬`4eFOoɚ_PUwMPkh?B9:f3$9cIE.⌲gnE`>|ݯ2QC/O=Rr ٗq\gCg}~4# 6%gе(HFqi)Uܲ\/Ζ5R惕梬n)ti;~aXZfsC8Xͳi0lPix}!8kk!qXVl&V`Fβ4yRW/RܞDr7N, Zb~:kL4 ԓQSN#~7S ~,98wc>#}S;x 87ߍsgGz^!1O}騩ikZ(su2 ^٤ TA~U*w`?|ʏ 5i"e~ZX,$e?SW ]ʊ֢KK2%9h씯kə9RKi3ft1 deeaƌ#3Xo߻wF}f!җF*?Wxԏ).,MI:}L1\-gϞ-.}~hɻԻ6h e$Z\dI _u/g_ fjj"vk;S{Ǻ{EM^1#LFS V 폝]f=ǣ/yWO޻a͈I0DCES^~@RUsWgfUfܳǜ8ߧ''x\Csm>_7]lnFrFK`=Ģ2f,Cjj6eӥeI(@ni 'cdɼe[*Qդ}5=~a:ddQ_b̭ӈc4gzo1=Goӗ߶m<ԿX\ Rz4c.!Cϝ:7w/c!Ln;w#̿Q3~xs`vǏ0Nn嵰:}^}K0w`ݦ0F/le*ê5ͨYQ+E2㖽5׮.@}s^_챴<eR3Yig9!EWX>~$~Rc'j2_P pV~"$l磪f9V(~CVQb'*¢}e99tP:mYA5[PP qxaaa|XcgnVyΣ/[oU|yk>k41(iI(* Mº;{ck =?>[}m1(99J]rJӓߩWB#ޭهz5y"({3VGYMkDýcqUUBNJ+MvK\e wFzNJ+PY]Rfrq9JK*䶸D&Ok7xY~ڨxNc싡V駟x8f DD >!IOq.̿Q+?prsr iZM^ǣ>c¯:ѧ5{Fϱݩ1fZ;f?|a# 1? ^ϼ 7xNShX]]t^UcEXVMke=VXey]'Ԫ<+_`MmǽctX<^2sw |ӻϟ_Ǯ_oSA^ H+ FFI7ϗ^Ͷ"KsGQ^ԵZSu (WXN Ghwn8U,/TS"9pb|༬RUrἼ Uj.7gESK-'$>x8{ܘu8>S34gLFF9*ޞC ^:FñeϹ&0ƞrO~:y|}vzٟ#Sִjad&y*y~{ƻ=wJֆP"Ƽ$ñfV]) 2[{ Rܺ+$i>(zҗgׇxЇn.*a2} dĽ(^_Q"=+UԬDq"uAKDM} ^S.m*+󼭪1Wɜ'r8wokh}Qƻݱ^ȫoBw'hhl~Jնe}Б穕'ws }rwk|} 1-6n(srמ=s=ҋ/Gmގ#Gsalԅeubh!傊%*oAMZn:Uf=F!)_ ذyJ smL2飠CBJsN},?b܃=JYg:;rWNIv4> ShXSZTLHZW 9e͆{8" %>p]ժXolPЄƕwD3|vO>dϾm4jb?sd$cbq1\1&774T[])ډEϺӧ$y\-k}$Ļ8w֋.k3U`g/TO- _,Μ5k՗_㓏?/Gq 73ؿ`~cj5!4uZ-`>L6asG7"0Zsή笜5-XZeQ(^ng~uF;tfӇ ݽ/C``Ż ݙRQ2Y|qΑ\9nֶ6aYYۺO85uXqk$3NǶ /%qll4԰G#Wu`ESQ~fXnCO[nE|whΑNn?m4;yxI;ĜYӢY- {qA썣sd>Z1Fs_ 汇Z:m1ϼqϹ9aaͭΏ9?j(e)~-4p1gNo{=ץ*ٶ}Z:qVnZSj@Skڷomh߶-# Rb0Y Mh\[)BLԮS}]_b@ZhQ06SQOC^<<2·\ɊtgX]ܲi%ʪ\عv%yw[Y^YZ5<1V^XYzukFcqf V6BˆVl؆m[8s,n<#ҿͧ`+?\̓2Dx?OZ}D_SM߹Of:>#%97|xν!k{D1x:"vx}Zm;Ѻy~V7Tu떶fl.m$gc\\7v^fUY^ ȹA#ė(C~:^ںkabx/)!$Bf[:M@Ӻ*ln@Eu\umVdmm.2yX;]F-wwwgyٓ% S3CA{݉W4ݲ7q=utgky{sz:ux߯}Yg{&YYOgL^;@pO_`„ =7|M/x?9@[['64Skt'c P^͊жej]f> ^hT{6H\xPE.O޳ay#g 9暛i̍H@EC&2$'YgU9joD]S1=+` oh[-kY#5IMW)!k>k7٫rU{7qs 1¼5{ϟO.17૯B{{YAf3f f͚%3};}~I]EZz2 X-̩>Μ<5FX?m b|OS<#s%Xs'gYF;11gO-ew'և 6ƍ'ZAwR>c*v[t7s~.tlRa6wlE $ˌ@CoPΜ~*.a.60A|{$[W"(ZցpE-B+dWh7?oaNw'KuBŪt鍘k{FCg 'MERټEb\tXs8MH+2vzE<1zM4[Y_XO?y/"|{CpNz@\s1>X!5e?gνٙ⌛͟){DFڇdC'Y+M--gՑ93/̽S(0kuS}C+hX-ב+%&_>_CHށĻfO~s]þd&F-ul[x:}_7+Sx߆ۏc{lQl'sWmƎ= :X4qhET3@zјhI*c-kac@^ν:[;Wa-'fV"y8W{W+n.i^&zm5`e ZӀj-ٰoڌnŞ$X(|;o8#sJ0Ut_.qz}q?jرRc^w!Y3khZ ~X=4܈(4z̳|q75uZz_FPs\:aĢC~;ghP{*/Gן*!qϬ/= fQ꒘svVM$'\6V̞$o]+xܦ^{X]۪P\kkd-sw 9'Zۖ/n:f{Y-f`͘4U)ȯ4qmmoKϊʵZ[~] w8C%uaf>Wl+n_/Xoݼ߯m ҷݵgf{o/DGF^'5^fM\S[Cs k{sNlئض۷]-JWaǡl_ձ{k=I-NL/mj]mR9WZKE;-7Pg!5_:Ь1r-Lf =Ο|h'f}in7rPx ˂8E6k&7}6k`U[&a<n)c̭ol݌֖6[^n7o5jbY-uɓ'EC lZ9O~8?ZӠK9K-gAw5z$N*[Gs&խ݄'|Tbmg$'M$o};{<` ק%`n*ˎRq2v:+版YC=,*NFˎr͸:.7j^?Xr1 i/6_?e~/w{y:I: EWw X߶{7U^aa6J枬W ڷGбUuT{`06aokpb}s[XۦbSe>=mtΞ`?:1"\} /lq=4=޺X{bnóg3gO o{;z8 0LZggϹVl."Ymb/̝!\̼әg ^mq=~07wXo$މu$z]8]asnwx>vumǁ;U׈d\8 N([^wa ۱@' k}ՂG;e~}y݉־ܗy}}_Z;ݡWuƷ*-k^{^ԫ\W4!399+;MG-6ktUX{53vU|pA?_|=SoȣL!须be2t#bޜZC[Ї!orݛ3gyu\0.b|=/OngO0u uCx'Ǜwugݕ5Y27s?;iͭ8z]ڦ DpZ'Fxn-:doMr oOگ3Óz)iS*V b%c۱i[QwTމC`]2sלm⫷BMC!ڷ7+`v&asNȜ";l?>9~Q1L7}b(9]_MڵNFfi/ӹ7V\?h2rbe,uu+vM ymx9soO>hDwRCc^{9=zDaw'[Q'LJsXWd>_|L3[-_O߇Ny\=Zst\pfOwsΝbz}=F2hݷ[oi]5NCUgN2dŚb9[H̼dwզ*T΃.JxQ?F4yO K#G;(1MK--Ŗ=+doy΃DWI|.qްVzYt ٯڰ>p-6$o߶Sy!b~/'ֵԺɜU^ZS|\81={;ri{=-+ZhQŊZsO?'ڔ{S֟?7__juG}6kkq8mm-q̿Kibb>;5E^8Xq|O^Rp;)RO9}O~ݻguKqR_,\ڳ/gp#GNsօ]8~ ^ OB&lhoı{eVyoZr1ȽE]B7yy+ۊ1A\qHіP6Kn;Ň߻lm[#1(w"/_KrXϡܯ9FՃy1 kP3um]'4^央 Vfݙ{EoJi{W\m⟸`g5UXݴAx1-w~>}ao!zΧe_ :Ժ>>|Qg˿q q[oI>8!xK|k5;b_=煦q#ιn}ZvI3`l<E<b]bqNqf'k҇5^}xzX<=ǼVwv.xgJ R#9_,3k+jVceӛgd1Gw6u>zejgfOqj޵=eƸZzkÌЌk^9ÚhyxߋzA1w"55csqNۿP {pؼYnY9Q)~?px`ȉCϯYYªw7x(/ ܠȅpU@zaOLX{ڼi:rsz &=`.ѿ~xvsyx8fVI&;ϹHΎSԺFܑp1׎X[b*]ڿWxA޵WbB4yf,cJy}f1}Wb]s1aK^cQk.^80c~.GMVר$ΖԌX$I 3cQ͒?g>sW;M߄/b<ʺ!+b:FA)z7ⓘ&։Q΢c>sCA'>߃kK/ZC\u:yxruq{755kx?|ۿ`~]{DKN0aٳ7st'ϜC;PP"5xqn?0XZ4E*c/y4o o!c~3 E ^;WĻ_<_'[O,+Q\ç@uS9;#ޫ8zN9+={-迥凈=ܽMꯚHkpo63z:~\ ib=1s=_Oy tF+8LFJ^ť!(*DQY̵(P3P,s_Oawށ8>N+̼ybR\|pu:TbVGߥ6>tD{w*i=^Gw!nƱEL+[pn,,{<8HW?މZ$0XIӅ[v khq4_I[{/vN^gk^yLAI ֩b0yk`~ Z=1;[x~p >X.ئ'4ka\ùhhZ75u4/b}2pm8~F !$90J/O:٘9{I8 eY20*ň݇:pXL| ׭/@z"l%sm~s-to]L#~m= ֙ˤ秠&6KOL8GKj0:#0CFbu8}!B8}RՈ p|يdmࡣbҺs=ynkG^Z>׹xk:2+++_e1՜+~͜;^u9ozJ,uF rIi!Nn(?|:2_ҬgL/<__'sFءLk~;1N3im>.y^{y7-Fk97=s|o{K9\>ݽuB{?osl7-߈q>s}'Zb9t=N ϝyd1_ *߅SgO#8yzuV~'СsZט =8/Y 2ue1 뚶+"z|g{sY#:3)Rج8ĥ`p׏(O]Yi`Jdk l'\Z Okq 737ǴV=?9 ~{oXx緷; 雋޽{9αwr[pE)\54QK駿閛ħ?݂yO ݧܫ3(n7 Ru\~;cம=I1'>x׃ߊwΪ`NޔP9n_2ڢ'Sx<Q!q/+^?~}'ñ(k)j&ٿ|N叙-W>0~J.żvZ|ysk?55= 0G\3c/cO;cn\zmݰF,{8/jdd!1=T|Ko эqVVA2j+Q^YB⾢˫V\-{rkt/t=|§}~O6u9`ii㴚k$Ya-kIM[iە˶l>]N*!M9(W'SX{P/[a64+4Ce;{k[^sMbf˱`[dTW^TXl#V>o?UafjR3{ѵ+qpl=z{` くzy=b q99O,sǭ6O@Ų G?Dǐ @'[(Tn^j#U8y ɴie4xN5W1?w}ن)Ҽ} Y&-+dּ,iШYnFi/-j^w͵{_{>a/w|1/zN4\CML~ 7oF[Rև%7.8=/w,_YO!-6T7DZ2td[8]V}UŘ_vx/ )[Z֚,>|Vbmn?gTa?}YYv7-|RĴ.ݻA:w4} S%bI_R T>!+W=D` {觻yD2΍׍Jwׁap1X@g}:'8v畄i\6 j{l=XW9>{T?fO#]uV-k$wZɚp(jl,Xfb gώ~d koxJ/$ o?YJ}W]HUyIl/1=揔R'rO&4Diձoޏ5Rm9&ݰiM+1^:zЊ?l*։V,Q0܅b=1l~3J΍=;7;}Wu͂j?º:\<:>v ux`c?;yop.tY]XJͧo:Rdݓo a~x0G^8X|_qGΝ?k֮2?>űq vNnWy||'k1V-47b[mkFGQsk|!燚9UC\rV> ]|U3gkǶJbJTxJ7&^_ϼSн0_6m]J윆KigH+zFT,ϒ~ %/OgTщ|HuyKrgu{?S:\y&WQfGMȦͲĴ<78<@V,5unD}9*.ܯP̃a|SwfqcNs-q 8]>ݭ`9izMqs :Uz- oS|~GCmXo~H3tB:uΝ{In}MJR3SA7MWRzo| |=З~F"Ťހ]?uls(΃}rS}`k6> RX*~ҥWoI&5?qpbMHݺ\*1 z:W/s+,=j?IEfVʥ+]T6WSaʕb̯tö.=1cZ xמoVnw91 ~u߿< X;>sy˗:iŴ2C7<^'bSCsf꾛|.ǟ] (71b9$,\1\[yR`tT^fVZjuZI>kxΙؾ!-絛R'mK%`DbqoP,`2ed2=;MB:4fsSh~>l\w+\xߴircI\T:v}} Y~❼3{FZT/HY'~KOzz}yGkwuj{l;iw*R셒>n&N RW!u\ҭW5Uz$z4}_J?RvQc㙫6V98<=K/-{k}S}ΫO-`۳16wv=22:i\-z@X~@+ C_|%oݑ7nü'|>?~bpXUVNxJEW{$h=$^94slٱN6&NhV(eh #5MLDMʹ$샥i%u=Pj7)R3JPd{F+*oUIj0d&3 ↓,7U2l|Of]nm|YDr Vj]@VMcjR5oڜފm_Nrr֪0o?6~5^Oc{l~;}-Չ߱ϖ3V?{^6jujpY\;;ػZͧ=|34i(u9k*Z OGn:!Bj4|YKcOW׃{8 mݬ6c8ų5v[qqS} xrzę<9?R8ٽ܎;J-LO(_sO=ュ ϮzCw{u:%I:oؓ'E[% _ߌ6 -T7k,/t/i`^pTɘ1XLl_q% Z+HDIh ״RTfREEU~׬[RIym!1eoR`M o$YsʤVx5-GwurƂ-8[d2hlGm;TNuqSl(7+6hya:6>V 5s\;Mm9#E|%>u_l:FO>ҵOk`_нXo;rh5Ԉݩё##6sB`/[;K`g?[w<#~b6?aaaʁ6N{DL3 ?O: Ew~5o}w磿R^#^+sb꽡I%[ؿit};MZUHDtYzChNZŧ&P&5n...)y.1Xg'b^?[=4/ƶ7) mix}1jïvyYyΫzsI޶~sbYtoV xJcֲd|7 nW[^nN{0oNNSr"&P纁+ f^7f/^r;G :>6Ȯjժ)f||{w.=A#`gG 7n|&ޯ$.xjYB?S|{_ɮe}&̑Rɧ6ڱ@a_D ѾбS]e|Um զoPЖU/Jh1G%^S/n 6WQE"bjmW(kb_ɚ5N&[ S<sӆM wɖ/lGuWNToyMz3얻~ 3~m~1։m]׋C9sW-IIMQD͍kOWXڭi"Ǯ5W^}Y5kkHڶwV?/j="Mg${#wuM^uކCw[v̩z]Nx GcmZyS=Pti7KNL3hIJJr=K9bV5Nݼeb^Ny /SXN zBV5ʞ}{pGw:K^ T#m[/{w؎{ zMm˰jڋnίX_LFm|Ԯ7+/5#ψBoM.c2oPyTP. $F/AwәZ*?w(tw*y[7ʦ\۪--U6_1_xC;ƾ މ 닉m)?oϫRͿ4iXui!EIZySobdݩŵJh(Ie祺bC.6f,ii5'*]\^gNcEݜ;c'?tM{sq[/i?|u {20yU~ [I|w&{2߮ 3]luWJ|Rܾ&]\:+0u4~tLu<6j\;{_Q P /Qu `υ?U 7>&sMUFMɔts 7Ȑ}%kW]+m7kZTkr")CzI^&~z﷛xr˖hn9os =\v$۾N~kxl=z;/>UJB%xV5BZ$[E^kݍԩKIWkp 01PbS>55s1&},|1PW!ֱ|3qO{}k8q{n;n=gmBfwfmw}:w#o6,!}Ϫnc|(b}wt?M[Jz.lپd\i6\3geJշl]j5\:@Րm%mu#*b;'ਪ2@:~|Dݝ1eG'H9?iuHi+m,jK(&CI~Ix=m?Ipxeе2c|[߇}yyaa7w[N,~|waY|g\yVoW{:͹z:S;kBߺi' H:7O.zB>)ܹE>8fu ϙ]e΍v6wHFeኙʡX%[גȸښCȶ5Q) N?jQ;[ffg(OD:R̜;Es Ghv=_ɘ8-RTxTe=F'.Wn9rsѡzʶ.Y<)2`[۶=s;1.~ΗyYڟ=z eসphW];X}ex0yD*WOѯp׾h(>{2CdQ*}*U)[%t}ԸVnx'sC ;hxrvsb%^K'];|-='_:w;ijuUp=S(}BsGijdy@vjl"aj+_΢R?߅u#Qm\b0ޤ][kbr?ܗytuCr Y iE|#?[A1$N5 iwl]uJ>]}*-ߗ^)hVIEܧT'v״Ϟ|3]y%&~d¤LȜ('̑(oӔݵWr8w~?!^_7ϟZkΝ3SkWd/޽vr![Q£$ilX'dN>8"飤 ~2e(ol|Ѿ|8=lߥ޸LZ4 h&wg/:,I6!Ҽ]%UuIvHDH6. oUGB*4YƇ_nuh.^~kmfq\G(+:rTv+;U.hoQK a&ly}w^,EڣB̈}Ixq.X۹9 'oOKz^3CvN}C~ߍKJI:/J!3BBHIL,Fik@}VұO _JѽCF Nڟ sڭ76`bX8eL%3)f+;;?woXމw( /W sM" ITZY=tZ񾣨P{聞t9ŵM:voy|usKL>u'-jJڃ:XZY4}ty+7*Hؚn72IP o^]{W0XzaAҫoݲZΗ+w_l5>x?ة=2{Di*5~X mۑk|cl36t^#S0D3VyMxzϘiK9yS oOlFm(}`[ ^pp<|)Ze_V# O U[]-Hn1Z=}/H<ѻ6z3Vm9=KIx?%=;'55aJdN듧Ԭ2ez>yrC{99;s~mw˔q#$_"k!IFl]} ЛXkN 7ʡct]W.&aM՞5 =Ԧ߮e?O:5CEBJ `q:FDŽI+D޲y]#+M|9["mc˲ETOCd>~@o}~:^`m/=VwPݷScd^p-YdkN7CĿNRIy<痔w/X$^{k,]9l#vnۈ])t }CT~407IHVÕ[Z4oxWiۭ떖Vidђ1FkbFJpdE:dL&O&&NROʐI2J;}̖?s p;NŻC: v21cAQ#ԓcʱM,Wy8=j[e#'Hκ٢X Wɬ iGSަ$l*q #~vi)--;6tKTzZjl|۱tHQ۩W+G:5v|plH|XUL:ލ"ca>_j"M7P?޵\9ttCtT1opdp_.ΙKwbA::'81m[>b?/uۑA֢$ @?_1)SջҺHE7?r& &-5*5ޔo0>:=MFLc3eƷ _xu:2*^&'3fΔSK&u2}$>sb'N9 8Pݿ;ENoݱq19xwg:"EB}+Ibt9~ȡS}Kad ,GO:|7! 'J+c[ݣ%}Ciݵ[ZuiFbFb"$m:(&XZwn*HҥW{8tbl޶ZIQk;zִzʾC;گ0DW> - ;#!?Gh"mG%]imo9JoKr,Y3We&(:D{f9 (wsBtw+?lb#Ǐ鳧e9mo,ZFHbRٔ+ft!#T1_kw>u.od >@o{kwms6)ڞuNl8ֽit΂]%UA8T1.X/}]6>z&LUj|}zseNy 0LaS5[w;}ywz8t컓c_wk;xXO|HƧP>upoƟ7߉rigvl&Ֆ?sH )ګ STlgg%z6s`>GK_1Nf,$sfI8^2M=$g/yMw|3'ԶyrJh:g)m;Gj?.֝"%!1:_> lBO?5n;l%-cJ46B"ipZ#un;e~7zqS;+ ѡN+M'69.B͜ﲜ~}_KGM7kgJzHxW/Nty%:uVK'd~43eonm7Ÿw^<) o MJisH}v!2ضCk`t6=۹qf9=Sڛ;NqgP'}A|y;`<1һclds$/Z͙(OKYm} ^'N?{gȔm"z,uhW=wyxw#q]J up{|sN0<>ׄ2{KnbroǙ˳/iΉyO;J»-;G*{R5Rʍc`;Zq#I+J_>tjc& QcX+1$ 93 ֍=]wOçOd\\.n~O[[;NPv}?sGsak$cGά3gOko3,N'.rr_{IzҺ]Ln3ֶ8sD._;}7jO4OzL)1KמeK&Y\1].s۩wIgq8!;7}[{R{0ӿc5~bur)9wܣLQ_S ]s'I+#- _gtae}vpm|pXL[2Z${˧fuv;ƭo15kSl3wb$>Ln ]֯'x'UY)cbt6 OK \~-;uϘl2Y2(5zCy4c&cY=Kcw0xk? x͒9q⏘[gmiJ|) 6Tt&vCBB{\Ӯ*3W6 nwvCצ2`H\rV.d˅r; Qwj;lh?pƂ&o'z^jok=HOZ_>g1Itlǝ&9y\|xU?/|u:+S`GjN) s?DzycΙ3+o׾{`=<~]c.)<5JyeA9bWwѫFLɇ_V,\l'#&.Zz&uS珪-:>VF!my$SS}=ƃ}3?s8k|>]$SfW{q.I=sc٪lҳ4o9CʹKFǝ?.~zI?cѾcSvpc,&םſڽ](n{*<"t?q-UW 䆥SIhoT ,6dƬ2cL5IkS*9HnkbR)ϕ=I}Axw*U(s3>9wgH#>PpΗwlY3h75Yڴo-Mfj׭{$>='Fû4wGK.ݶ9OOT?c`y2̜إL(A5WB88W_}U1=|I-;k 5wt/>u^Нi5J^y+W(7ﺋՉ }.g} W.RI6%g8C=N3yκw_19ebr8=:.X8Gyc%Ȃų vɥ6=vijM?>}ԮXP\/ǥ*α܂rZ ^N|Ix' 5Gol1ryր/Pp_l%ꘑm>}Ty[s֏Gs.u:<pı.;wn*W0Xo1lϗ1<p;*\ND8NqA~0_ߵ»;񎍷5xx*ƎW*zz2~oTzSں$&]I IOFO)=R:IeĻwhWbƜ, Q_?B|I*VB?0Swci}rشS\~u-SgS^&nnssA.оϳ}`'vnl\0o|?O7jC; QW JЇTxNڮWo0Lk{IƵeT4 WAU%؊${g/ԞD֐9e[yL_;a%'Q7tb~{ slbt^9\)?p:G>}*'<_h~yW_?Twa/*;ֱ6Go{WNc$kջ &‰eٲu WSȊ5rqۑ+zce]2\'=SJIƇc0S'8O4M5;edoQ1JM[ԷL1|fe!_5ouM_=NOン% O^{]廘/ƽS_Zȹ/2Oo 4p<>c*p O[G`#93/]^W}Rrw!DFUS{9֫ WYY"W\xg+dμ;]eϔacuOͰr7J(+3?cHW4@RFu0/)R#KFfJQʉP4mNɚ*+VМNR9J60!cW/|?6|Bw0yp`dtēž?k [OZW#'rAɜ4Nz%v:|.vo|d%ݏ+${?\dobΒr|p|L=e~X'~:6Eܦh&`vϯ#Hmet78;CٱgݷM4F:9 > +y8%8wu3{kgx5V\Aw(ñgu:?ۗ,=g<&z}nۮy݉ynmTׯՏΛk6{JW]*L}rQf̛*]tsؙC2|`Hڄ&_n@ >Pz$v4~t\::kT?V>r0gϝ6>:L@1ah K/~Ë#v6UJЗl?sѵYrV)ǜ[l88Em*tWKCB{l..o?-65>|zfqr嬿^s7lͪeg^(KVYTdCcfך4Н?w0R˷w hxU(W,Zɔcd$p֋L-Z>C[WO!ʌE#Ĺrj߿{s~07rƖZ}?>:z~/d˒Sp=vhN:vU)ʕ//[S®b|?|;{9?f=a9zGr<1pHJޖ%uӚN1vygnI^u;[FCd!nnwp,YP-Ç>}h\k w瞭2`Hѫ{sB7n~*>5>楺5ռ:v_^\U<W|bn'9n~0hkoȷsC9Cs]o?>l{ޓ^墳y];6j 晻ӝu5{jS+rRft,əęCǶ/0L31V@?)~Zݹz}._R]3o2h\л+We2g$c#t9gpd/cbYl,[=WĈW'j$&>vYcn5Rٻ⽔Î]w'Q12brz#͠٧FЫkpLI C7yj|n)^wk/?x]-} +z=t)~ otݧ?TopCЉrpͦH .42^~Czr^d!~Y9phϙ 3+ϛa%)W7\N=: o=oRqzUw\ye`C16G6!v|ǎ //W?߁cIfR5ij2ehc7:jw[g2_Pt Muc۩>Y$74МOLĴsnޫm5Xj2N_\^rzʪ sуA-\ްCUgDFE(:^߃5Yt^";^qkG`mw'/wĺ C?>˯nkpLeq|v~`lƧus;'~;j?1b2hxGaȊ5ʛzrgZ׆=#}|6?\>Vul}R)_]y?|jhBG{}PcY_?k7߫xK||[7kL}ƹý|rX׽׿sCl}G7q<5طwroٲ`~bw;*7oPN ūˠI)TJs!v֜?2AὌܾ(e~+e?.Q5%yxg'$?\E2u|؊20Sf2jA/=9 WOsߡRW{>6صŞ\ic=u<.\&O K{v6{ǎ:Fwmǵ󎻟w߻_úǟ)C\vy{3?v'\I3\&ɪ5Sɘj:yW|\4rrc2R'AN%1Oӟ<;ž+vRuZ;ozn'r,c˟;~._-O׾5kVKZ쟞1+:v^Pw$;ed:v{޹K'3fNי;_5jii@m#WgL95J^ _5;uoџO=dɲjGNAbt#{$S&L c:"2*/t_vAgr.z`lH݅nv6yJO̞}n~!_w͙a>ϼ3 {0+L4CYrx.Tl=&Nԗ`pm3?O vκ.8C˚;;$|6so=[dKA^/ͿgG-v}$7OΎzx掆c?x5dL/X,-k͟w^%17}$$5ߓ-GJ;ys_ OnؕTALv"k֯֜cy$0gv.j-/11==;w'&ķN˚SRK˘gΚ?\g\%9bגc+`U0>3Ѿg׆ڿSvzkߝ%܉ua{-߸.ocWFe{Kw#Mj Yڇ{:n%0SuͱejO/MJ1~y?x̸?~y}K¼Ӗ;1l΀p 'h{ا}{ӷaAKb~nKXA?1[;nRcӹ-ǮgsR{_vyF×BIn.X.s3lWx+7xq;}x> u71$0w̬4`6UJ+VKکq"{jj?+[׌x\_[п9o=[8/cѽG7=;v*krN6ub7mŁGke˽q;>=b;:: mmk$D!&En I27cKd9N/W ] I:Xy=>8;v۩58顡j_};T|f+;9UXyqs,mσy[~f;Co":1?<=={-O"Og?6ŅG_n{6wz=-Uɚ5N65f)y<Ԝ[zÛ:+C5W{R̃wB!OK'v F~o*8>ճ$eXwyamAs6X趼ղlLj~;^--Ce[Que#>5~)+%h{WobvS?k) h\yϿkc߭Gkc_(y܉oųcro8\5[3ŽJj⩓7_}u>Ml9 b{3p񯾾qz$7Y|W?)_F2>+;6}zsOsJIw'歏hp|:ͭwM=z|Ib XǶq=q}~nKYZb~ڕs}[ᖻ/tǏ'77m5%gYdL^.:{z1x'f_lL7~/ϓß'G.Om|MK:OIeTe)VQ)OFEWWu]nAj;{A@uֽ?IH蠹uV9FWϡ4g>Fot>y{8O!?B*W_A֧COgw'}רvgsoW/sqv+nY32M|XSqZޘgKfNd~~7:`ȡ^I#}p1 TܹO7nˍO_߉}g\o;~|mQh쀁:=lkW< oM跡NO;X+]~k&֩Ó_零2 ]zňOU9U12ob`b⠲˿HT {w<;3EikOwi\=e _|!ݲV/ɒ-k)8Qr  cq-ς{n1X6b5Αퟣ~gZ[ot>שsGPB' 6gF }CwӉsO{WJ}Žᖿ-:Gg.c%iie W>}}ȗ_|8WĈŽ.DOܣ;N?>έK6bytQf&3{K " 0?^V"KHz󺿢x<\ߒkR&gVaR-M28Tye+3xS%<ЯSŻ;7A.6/ ֎;6&ƵVg!|*F」&ާʔcҵoW_7 >?Ǐayaf;xtSGuCYs'+g6{7ޝW;~/?ܥglWpo{ȝsL9G$co{Q{N=wʴ\KU)M|j uo`ZFmѲڻ/bஔSJe-U(;IRAy6AdY2gtrgF}7_PԪ_Q-1յNAǐci9_]ڮrܹv-M6U~!yGGUʕ++<ڇ|=S[n퐵IO*ƞjNy$no޼ 1u1׏Ox-y?kC}1>5؟y n~.>7ߑG}kʔ)ʭ0yd:w|宋XS8ԡ7]۶mݼEg{Np?y7dsu&}qەkQ5[gx}Ot8m9ضW@:AӶe"Ǭwq&\1Vл|~??=s8}';y𙘯{j^||gcqx9'B]}o!ٺcm۠=ߘo_juo.3e3%gZ]++*`pT zY[7cb}AVYu*ߎwrwghU ~TʙxiGɜ=Dw V Dw&+=_bt^|jT5ǷzBݼN{59G8 |G+HϤRXYb\s(3RX~~Ɖ{;35e9--[t}'٩^{Mmm&ש \k˝^.9lo6R =8/o޾}K5Á:~_]iP_r6-U)Yo(%x[nxf"YW."]c%n9U[eYP/8(xc#nj89O;p9ܒShu=Vgɝ>yO\pŵV 6w|:`&gSwvǔ~Fs_}sc19gzǹNk\Wnĭs6;g9m߳v)ط/)y蔄yke`rԂeW{>:]?=Fc_O"<=zv_1 wj71ko&۶o&J&w_5VijT4q>J 'dLG*!ޗ윙/ =[jwOi/^Z%=RdRQ2yYZ.oVzLs grm2:`3~EH_<-]|]#r919zrwԹ✎g=|}}ݶ?yϱ::<%Օ5tzxurX$=S'9j֧V[{/8{"A|pgr q;v~2:hl8~S_ n߰b~V  -ذas-g&x4g{ 7NEnެ}6oL'>%GT-vmr烿㝕/;/Xf}NWEI.6,Y1_Գ2wlkS~ay(m%Zblݼ[6mءVH==,%=.Mבse@*f Q=<0+}RÅi3\i;!jd͗gx>pnw0'`v+}䅩DNݗ_~ay=f`ȘW n-/H-س7nǛOy@q]*5֍E>G~NkCzn3- d9:WEP'kvbV;o];͞.JKJK\B= Ǜ8zCOɱçOgz܅,1gh,͇kM;~o%N`p\6ubk &_CL:4xm'GrAЬOf!AeP~*}?|wyڵ^WqGyˑqy}F~_Md~}uRXkE̟&$4wȒC%sLߢTLJ3iWɬRq4wT).#&e};N/W) F&k^yߎw[3h+8~~zkj5*{+UΜNH/+7fZgÙWUӊRdv˞eʅrtIiRN|S`0oz2~OiY~[6NMYߛlX/;)/l!vrufOݚJ.|N.ps#f6.q"}=hX6Gij]}_9bO z5u<0p >Y_G»o}cd>{Qd%¥öw|z}deB:_Zs2rb_ټsb|'oܨyA|Q[| cw7ۃ‚`sX S[na;4l*7p\7iǥk.SpQ8?B\C~:nTXAgfPA6`1S\z =n-~yl87߿>O >)'7[<`/܋'[{JcH߷/K}z'۶oWNij./;)_i=qlٶumڶN]$m;7gL9 VLwHѠS1d^ҩ]XfR|cxWCJT}P8,FkQw4,UHqRƳR]ISFk=r$i^ y}|a3 Xԍ,㧚OhykE6ۊm 0 619sl2>h{ &n=ope+Va!?<ëx+_nml0/;kcNtwq}?znx 7Ͳç1'2H&Ķy{Q{GY ӥx:VboflwjӖ'vbоU.n=uhXN}xfRoG7`_S/=g+ޤږ VE-RRMkS>>aw)Y@{4_\/]z⥟Kɴ9#dֽypY0Vj7(#QU HLIWP#9454'8h}}S_Rni<Ӻو#Z}pɍkcsɥ˜Ek<ebzYhc}| `Cq'ZsO\AA30mgٿse>{ö?{{~l`0elC̖6İv$מAX+.NudH'yF:[z܁YyB_ZJ~8}XX'Ţ/<({4QSJb)jR\e~%w?;sa*RUl?Zdđy-Ѵ7elغX\'II\bMٶyضOc[~vwyPaY_?J_<l?ȟUo|ڮlMC鷢m}?̉=ȑ[%' L>,96{sx,f'_@>|v[MӷvX˟m9Rlu @E/\6ݰ\sC쩈x'Oޙ}ѽfRiնԈ)'33.ߵKmX/wnJFUBw)>cDٰmԨ_Qznю_ ݬx/ =hYlQU^Jֽ?Yqq ~OniR3R2}Xw 6z/JdAe9zl۱A(k *k5qڒ1dܫ<4S߰;fZfҏ˥%oYn=c'8V'F] N_D}V5zd8//$,&{r~ )Z-C{۴> b-s}8G/0~@[X|}hHl\Eok֭wν[uKݦQR̃F+eR3_q非$vQHQgWIO(x79};hYXke*B~6b\,.O6-3珕=tR~vnw-dNeTv)NƣAtYTQ6)^uLυe|pF?#\?o{ץvOP3+:yoxrjhK{U~paa۸?c>SOWyz9,7uMoX!'o/aNm;tg{Fm}p^K};췉/(~hY;:} 30r􄏘&:|CG*3W,ئ5`HdQzYf>( WwvToT\md*8LRIEJ-oE]ԭa[w{ըgee[Ò|[F|]ҧLuxmXSJ'֑+gaհ]8] [R[Gv9#ckٖS5Ϲf(QBU|m k4ctD?Y5;x!iS3Q}PNv ZrY?֏ u1o͇ۖXזφkN-&oy߷uxy9;,|Ag{ⰃɩeҫO;Z4/qq殬tՀB󩚳i㦦ˎ}uJ&U=cR$IQ)SaC$/ֿGJ]/nXg=_R0ORCzF2u&j<- W9s.V17dŵ9FjȪ5ՇH &rgbeɲ уu0<֠H~:6[/ӟT~K\\ߚ)Xz^=yx֛f#g 99@䆱`_?\=x=~_-I/^Oϻ}}>^P[odezM/gϞa}i~~ҍxjt>sϴgO/ox7sv9{B6o[#ԺQEQ(1o;%{vdyizث-4[wJzBOɠݝ0~vle~$<[xy?_w W"bU$%,%R5܊~IɪdA2yP(Kͻsi|#)VtΝC>}ШY4h\_ujY+Ku(c`t|OΌ ~n=Wy<='|R^2;Z FoN{ڬ͵6Es {v)qP' /ԧOE#׏/5/4Xn-惙s~6"~32{֜poO?mm…rEo'NSgBǝm?{l߳^z6>KI͘J2c,9ιgKd%:HUTi 다UrCn2tB/_NyT_ l&WoN :xeu] h:PjU ܥ3䠋]|d_~{2oa>&I-2ܿY^zϰ+W9r:] ++gkZnO9o=S F]gs|,vkOK/g yGw&=rxhʼ{G< ~gg11> A6r/B8?|OܵMgr+j?tOuyn+9W`~]$ϸ_r1,ܷsamТ|i*Z&2x-rnu6,S@kJm7 $.1F.Gyz!7s K酜_=x)[.hYEޭX{xwfбJG?%b HJ1Qt\5(Y 'Q6+ YhGN g3tn_TB܇HZ >}L7þgy٭Z ܹۮOú6\ߟ=}K^U/lHx|s\'~@]M~/\g]lꂡuI8u {MK2 e?9H#gy{7'XK// gW]`u%ϟuKr>7GSAIǸxD}{Ob`T9_ftJe_V@%#&JjOl9,x7n7w}cI afȶXi)Y OU3̵;AZLt{gw!U}9t4KN93ш4%ʔ5B SzaȺ)A9}>DX>|Ba8pc:Cu>{4o,n5wTP!tѡ}pܚ~ژXwl.5n7{t,b::{%pr0['_\?_v~ٜ0)ow+^U…:{1Muqe=r6[ĽRR곒:d,,M8-ˮ}tiE8Y~C;uHڹg,X!q u8i9AZN:^y-^zafD#kg@hf^^ǗG'tabs]ḃGf>ɣ]$gOSo7=ea{;}ݯv>R|"N"Xlr|:qH=68lJ+9;O=uFRfiiR&O*ǎ׵_b}%a}UD+y橏_z U[X8>Ẑ&uvDv]x^k?x[P^aqh\NjYgu˫ά#'4_3TUU:vIUkWOQѩG;i֪Qd^ǹ 'UoP qú7BXFHo>/̾x ݗM4ѽI9tr9C= |zbo7 ݰo,O5.](',RF_>EnݺenXcǎ s}wiAJ^Hﯷ/'j9OE}uy6_zQ߽~>t]8G:j-_ndY3g8!GVcV'-{oq>Bi۩^T'֓QSȘiJLyRqV}|{H{Bruyo-9:zd􃚣ö+k=|uMKKjH|2r5q4hVJ?sHHŪQ>A.\>''ѹ4|I"1FwvVg\_zxl{:וkޭVyjѺlܸ̘1ChM\|'cH"^͗7[n>|?zH9gA<gzkpL qc['zAi׾jg*Z^zu}ϋFtύsΟY^vEvݡy6Z㻧vP*'Ϝ)ѷhߥD׫s&'Ng9~EJ?%&E/Q*b|g@+Gl#xW{xxl;XgUy^jJ8{To]IRyeY%S 33W.pQwM7߰Z眃yftZsvӣw۰By=ޯ\~:m\ -W 5,X 7o\{f-Ufۃ{C~'g5~.u yl|v _8#xO?tp;#GBޯNkl |+Wf:i̲ި>h&XtƊeɘ $.k-/>~⤜=w^6oe:kػQ39'Vn\$R[IvEklU)ŊuKJWM)N.z{G]S%?)<zou "Ҡ]tR۷Xku KKx;z޶MJ5>w\ο|F'/ڡstFz$ˮ=vjW=3ۮBgvV{7jz=s/.sP>gw>o!2ʗN%<׆{R$ }KoSwDP_f7m߾M{yh٪VXn5 '/-`_uaY)7?ԙ32nIXH%c hmںYL+Ġ'Ȏ=;JBҳ'YzN G9^ڻruR\󠔬y_hwܫ\u~滁P=7]|{^iEcܿA(z(Nҵxiݮm2R,3N(ڦ9:ː}u)#  Vz2޴u5bl9u"f^!yvmL<:j(pbuf 5=|U!7+6' ,3Fsr-6eYԮ<)w8mАA jȔ4Ǽcf5[w*_V}rM-|_ R+7t]ҾYzoe̩2l]7\?~? ƫ \=3<ϟwoסͤKJ{1w:wH.]~h\taK5i]n}wiRFIՠtM={L'BR3bLǥt݇p^/ x>o=k .۶w]st* 8^\nXռ4`>cTg(j(gϟvg)4k(CG<.*/|VzA6n^-^s9;e`0n9?=7 ;5$Yf_=Mc OK m>u'1\-\f*~jg>//_-GPtMn߾}Zqç:mv$J{>,G~1Y&KͶg{Ķm%G`|B^}9~T^:AG#5Tә hWʘg5[r2鐜4ڳl۹^^늼kۯsf05u,Gwrf ;jV?pLJ)gLS 1TXeG\KkpY| 5Bbs~cdfGwH~AjƂqt,ek+il[;DU.i{:Iڏ8s6+Wҝa^{bn9Gkޝ V3+0l{ gKΪ׬4Mo|6Zۤ.R;tp>-k^qzŵj*8x` gIZұKkb;_w޻tO'ozuA^9gGpKl<ѝB <`s_7n]C&%FˋqťJ|gsὔ}no!~{._ްSbw A^7E# _ܵmQSKUҠ}/ONnKΨmo֢J*K֛)+Ѻ7YV_$.s6Uy㭫:cV 4<{<3o0cjt$Ə38qjOp;Z5j )[q19x<ޣ69Kjnܘn7_*U ЩǙ^v0fl۶U Ji1{MNh{٨bRӹ|L' AXlÒ%K$55U:WN<kǵn9Y'kӇdtpi&)+7ϗfmkKҠU۴ťw|Rutxz"͗ f}u{lJΟUm\Y%Ȥeρԥ4c+~ԸҶc+ýrRfƝ3g-=t`Y3ʪ<@ >?15|IxVP&?ׯp,?N4j|;ݛ6iXD+ÜI\RX%Z:~|?0>_6; \NѠA!޾$^A+W"IҼeSYbaRw8&!-Jf~|EE!^Sx/Qo>ѡ4yuK h}Zwu x5Zkp:Kݸ R]QTC&EKu4JXf-$wX4K\,GOq~gi5w.W^w^YF a5OL:pYsC ,E׹a>|`ϝݷoWOݷׯC'+V(]v9}}ne΋H/\=1gxkpݰjXY;T7m[]:ח&5uuA3s;l+[ūdm2h@i\L_:_ܽU5 gjYRw{xkU8j~./oscЎ#nڸy.n}]tu|<ύ4:9Ŀ =r<^X!5,wF%\a\ |hf:9E{֯U qn/<#&=rY~N}MP "s~sYz;%/rK%X*URWʩ3G9{/\|ޟE4S]٣dO60m4lQ[wo%KVgHƒҺs3g}»]p7;εm; ޤmUiXU޺Ky:Ҽm$:olYytwEޝdwy}FGNQޥ{{k{h~o~2zP|exp`דbmcȯCzg^4۵G5r`hZaC3fo׼^з5œ3l?c>}zz7 @n|$}Q/OL_n/oeO>H}q.|ϴ1g3z^꿽뫊Qc)/8uTs-']\?=EbԐ#zʍeʜ1Ҫcc[N[Yxj>މeoR]uoaμwx떛'vKsvw-{+KlkŸo۵Lb6M'ɽmd i>N,Yȵw-vZlggޱ͞=Ck`=.3&f?5bpa_3'Y`2g[mz^̶;[ɹ srz=l#GP{L^CϞ1uo Z7g "nx!\<׍\Ljv=5|x4[೘/s\_\p~}w|; 7闢XgV6࣏S5ڗΟr|I2w yK·<+M&-IJ.n |4jY[4P$X>U~}ծYw.c2ém]_u7^/a:;s9Xסy=i\_z|R=|RVwQʏ1g;;uƮ>󳼿qo+6۟Y`v 2z>r 97JZt(\y?l۽cO_S}NPqZҰu\7 ƛay7oaʙl|_sq-B9Y`=TLUJn׵]xiۥLj,M;KڠiDefg˶훔W;lڲ^}64ɃOy|M6{<.;e9*f+pg3h±оsycl޾ߝ\9^u{mu ;BZ]6?X$#9Q?$b9 -rծ}[u֩%uL s#\Z^_k/Oa8x|)?}=eĨtYrx~2:vj'dW/ko\y gjfećė[Qyy|}|zx9AԭulC~#u;·\FZTGcN uu{nէ'gzrٲ{J59K2KJjw=wܢ/q\ok,'wccct!Cį1 cF 2JӂӾN+lp/ޣMIO9qh~zo30'MKל*obkg#yb 3q;9F: >9ƴ԰abuv4]j36C Pd:}Ծݴrɲyj7,%4]zbo+UiHÖҶ{sWUg/{>ww>.Ͷx/TW]g ίS'h#Ƞd۞Mj2Эrl['~s26yxylu"unW¶bW-${pyC9 1w_ojY>'>siyg4&fyr, Gq3oHݟ9߄yo9ņ"A: ^<_>{o7ͻgpj/Y8|}O޳w'ޫ,]@q/˪5ِ 2w ٺk'۱Wk͝Moݹ4IZM_ kn>׍wtug(G›j3 UExgp^_] նsx=}]9`mң_|mӹ. :ޛriGSc?0ToOǿ' ]_ٓAA|ԔѬx9]ӄן9]c/Z`[|v6GWù3XLph3o_A>ukqkH-#~lZme;plf k ԞSΎoOM~5Ǐ_.S:8rbd$uo=m6U#!F=]÷,{̇v%Ø>0OY$[|zjte[mgzNnv>Gk{j͝1fZF0]ǧ4F׎{Z0P+fY}m09*㳂}0C-!_Yžc68{K^4㱅a;| gzuv?9A?|Whr犯4K<17B$ \|e/$&‡C| Υ Θsֳdϓ3 Q͵P]?\ξ9·cjR陚k ٗCp\Ym6 㽅A Y7;+}=2y!mn?yu?kW_̖I rE|νI>Il9tt=TkSOTx_𑬜{r^ћcF:g\|߄6}5 vXǂ}?Ox/` w |!}p?wϓ~ڻ?g~<,w9M|jVc>g4"̕ 9SPZݵ@koo܄QYvޱ훶ã{V~}I^ER=)曶>wnwaB6ᰮ]un:uI`۳ny̛p] :33޹w[{~4^vҞWm0O>P gnSv ?׎8,jP],G _^yAម_epȅa>4zrOelCזү$;̷\%x ͧ7<Y>ޱ>mwjtw>]-mDѱ)٨m;~x:/߮P!p.tl;v=e`=jSm3ٹk J2~LMjY`}oy]rswbupK|>,&g9kjn`׷J oxw}6PMSY-#>MM ?V6W|w'HcǗ1;%n*=irgcyý=Ƹ p^Z?<Ⳑ]qpwk?98`| ';Su9}uiIK wi>9Kr2}x7ZΊGxW=*s͏tsW˗V<2h}l{-{}]:(}ڐxEpoXq;vn-+qdrN3pϾ`P n\ֳc%vyHƶKr~p`QsE緓Wj}nz39CG{`pY~jo93#2kQ5grt` 6gQU\Yo؍7BΞ;%}YB %ȊՋ}ImTc]E{ROߥqȧOo־b>~\>}B|z4|/*}Uz`Fxs\ =]{});ːa}$o/?yDۿ;\ YnkSJ c*^7Fxgx]}zs[֧]{XKrw|?-x5bOzw4 JOz5l;[+vʴ Z'ebsa->7>89hxtqd=m}}@lmORohZNԳrKX~4,^XaיW=45|"vs #x~뚟`| \3HyG}sY֣Cle˖POGz!>Pq' }ʯ~咳ḣ_ߟS{/{POHIQR';^aӷ eûnw;+w(_9$1n:P^wa)kR<< JUzdXz\9%-+JÄʥg6)ƩÑ>CzIZz02U믿>o=sPm^3dW]*c³%_?q8'viקE  ig7.Fp5bfh/mɟ'j:9n8`uʔ)gO" h՚?H=zDԗ[ޣi֠VZR{l}"Ekrh,l8:C̘gիdo߮n詡1ȑcYr;uMO _\=PZ6x Ε.siɛFms͇BfKN?̦}YXC8Ap?gu8g4&=wߑ{vɤ)>Fm\s| 9:(՝-ظFq?| gx'Gޛg}k7;(P-Ayـu>z}?yoho2l޾V/#Ʀ1C7~7?yUR`{C-bnv,wh_gM0AvJV}S!,grojm{\r)rZvuMu898F%x|snRӶkfE0ļ'zʽΓ/@O"5z4P~Y.0i'.(|͝IS'ʡ=R;Qx'{#wびYxQxJETkX4˃w3 AJcݯ+">Qt^Şf ;i8}h1LiO{/%μ֩S[JJt]}z|U;Wr+~-;< xÇ̓w1?_˔SՏ߰i9zb=_o6Ƨ)Qc#|CR2ӳ].F1:Oox ʫ-8/#+(.7yww\l̶nxgcx wICeĄt78E2NsQO>v:f֍Z7>اvءٰcڵi-^n]iݺ޽{/N_ sL:Q7r0LCo6k* γ?z=W czy_fdplpdp|=ŏ?L ۵~QcG+?r!O6Q +,יN[ƻwn>Ooxgxgn6w坯k}ʹ|yQ!'DĻg;?~͟f؁%:l@ٲczG/O3{kq͌&g:&siJ{ # mg?Gj}މa/4b'Ozm1pHw5\a|0\c<0>b❜]N=N.g\xi9 ƕ7.˧=7guxܼwtcs>|Yd2~(3{a'c?3gZbZo6°#Ϛ5K{szVײ:ոLjoEQ}{շ" >}[7ysį߫"|#>ϥ  7~j`ʑsgtxs|+3gOȬ2b0YvI#ch7tIyJɊ_ƾn<;Q}H~{n÷!~ԟ'gǬք)eSoG<ǭZJsV+cn8= .Y%6ksxOmǛMw6ɼsw|?>yX0G}V%9/[)M}đa3ON~N,dݘMO$:F3_[/H]Ÿ>|y%S&w˿N\O(xc g`br\}g-~3uv>Cܥz֣gG+Ѳeԏ'8Wl?Ւ|ik?|}1޹nG!}]CT_8y`~y`sg͝9Z>a(?ewg Wõ0Pנ}5gl"5qVZ-]XggqAϝ1}X3ס#F/2:!ƣul8ۣvwٿdҹ2olgLJʴYd;x=~ Kc&S-]Hge_ 7`mwcFXnNnu O=rX7P^pMBm)>ӓ& z|xbwM <~]S˘ICeԄtpOxfΟ"Yʎޒb\4]7S3Xc>rw6mҜgq~r>3ƩC5/Y-[7ێ>{49y8'Oo %SD:toc8ZV. MSNM҇ӾqlظF{ʧϜ,W_yYuJ М+Ÿr<33Skrf}=/J?Nc~}z\n}rqB̗g=[ޏi=ywf}1ϞL8\xzolزFkn 3Ӈ%l;?N}y\gևxkvfTV{fbTK]mjI5A˪n_)#׬lRZUAq[X*/xGcHpSmT=8[0[=֭DZ8'N.ЙR?lܒ|=yf==45SVםM+dyo}߿6{k|q$?ծOK/=qtL-"4н8|60ՋSc\P-mSN56ێM7Zx=^q]ֻ,i\d xOI" QoٺAz0h\\xNbbs`bC :z]bE~G>zX| :Uh?oeZVuZԣL1=3u?iH `^3xlqOgm-gϢ?k(sbO gjver Y9G1O :gtxn?kJ]Ǘ>=^2hhڳMg[o_ӹfMH׹).fG})xsx9$O;/j-/х^9?ih[2ͳ/?W{#tfs ږcMjpfl7OT~ YbCԙ&uF9u̞?Ukypmx+ ;X=A{!INzK]C~J6b v'ό?M2|.{D}Gs={zWЪW?]_g啗1o-[̙}3=mzBpM>Ю{a9uۼH_x}oz:;=n%=}]>~@cy~]}Pޱ]Rڪm3ͨ1#|]Z澳O lHB؇iӦEߛvUc-_Mza~DHUY4Ԝ*΂ a9PGFwíCd'%KV$ӎXωSrz۱ xߌ[g3"#3LSp~xdֵ'o.ٹorƧo Mas{l^4n_|X)k/^e܄:S=GjnhO2N&Nv8ug&xBwrtSM`Lc=zwyj^yHzbՙDɸfck+a3WѬ&M}b8  kb㛠ͼ.yPMӣ5}z1|Ԇ3=8ܾo1um۹E}~hQs``/>;3>yj]$c 9x gI>c'TQCˆMZ\$bz::ucMjrcr#nq`=gj]hЃ1:'wL8tcM}ֹɕc`ͱ$n=ƅs\ {Y<]h̨.\k_կͼorvIӰeѲ `a;ֻoWO1΍u6_hOkủver>$s}͝g/|.n*&)3&v^}߁):0qFl"Ȝ8l>m>IccHRJn4u9=Y^ˆ ^f/ʂa<ٳss|2l 봟iymYn 5T9il_՜=z6;nՅ?8U,8uliWcq˜I'i\_2{pO/Oum:%1;32gtVYbRҴYCiߡݷK'UcI|9.fuQe}o|a[ί`'\xj_ :Pfϝ=431rlbyαwF {.%D+z7{s=8uҶs3Źay.,: ;|z#d1ח\#(džox7u3Tnqjk7LB9/g}ҝYCŽ(۴M5kWof3S#zO<vY:7s%g+媻^ ߗ)U9ruO=f+cCڨ¹ϛYaǶrޱ*1Er᝙^%X:OewMo\czlغJV_*I]Uo3Cme}h;p9S:v,l,OoՓ6imş'Ng/Smoؼuly]:ixbж`,u686_رcaD}[{A,p;Յ'yGy\3ͽc˲^X:[F=i7nP3G]cn>zΎ\~΢Eed>u@̙_D4;~yR:w^/B~^N\x/]\xEQsm8,E-x,eʇƮO9YH~)e:tP_s~>oyz_Ղ]'/d\ZxXLs$}~.smdS10yXs Zn'O$={P^fum=l>s_yߘ={v/9x~;:~?ٝc?Y&O?<yo[~yowJ~s—@zG:5zj~O;>u4!pmӝoUc㇏r+ݲBę3M=qҩgٸDn^{q2ex9Y2cLs}r+r}h܎?ߺm#ҝܩX¦_ųgB5{A[ ʏ#q7ް>><3=ԦSs3띘`>q\1^~wbv&1~|>}5c&q{Op:cg_? vbbg$?ُs=g!^#kX|^ƣZС2}  9x1 ]jf̞&yu1kkjGٕM6Zvj96 AgݯW!+/ ek=y ,Yhƽ{<+RM6 UM1*G]̟/Q㿤TtL5!'gϟǶ}~=.hpyqnl2wOG?ɓZςOO&fێ5Bv뢳&蛃ozu&~ܣ!\y _zg)S&koŭ-?9ۛvY<qJoq5=W]Wqpl=vPyZO|e+k.+/̹륟z_Yvtыٵw0.eri\fE:հu5Mpq{R7ԉ{Qjs8jpR!b?>?g {7}7 aۦUQ*ҴuķxoTjԏRb6#c'V}.+3}k:_v8"o<2k]XŖX;i&iBM-4M=K-^ߙӴǻzI&9v|qj#G_,Qf2}§xb>0WyfI=Ê ^BޫwO0lB}ypŗ^Pa߭E{;wxCgFk=X&jpXsg_R`Ϟ??sw˛\_~걉۸8c!=v>=NLjF`frۼsî{Qw*>yy=l>@Ż3uIRIgզT+}tyKfʕoܲj&:{,]Dx_]+?*/UkVHDZsln`e ؎^jr|oϟoڴ{uرӧOɢE eb=&Eyp̗b޽7{c;/A/55U6<o%N>Gӭ@;NQm;$Z{8w#voxǗoکG݂-c`j;ڻyuu{x]1w^;>J|P?H"nް.;viR^N&ΦO:J7ٕίBs^fxPm;N:]fD|;~SǪ>l`՘_a>#핡c%>Z|NzyX'f7#o7Sjۍ{Ũ[3F1Ow<G;8NM OԺ-ߧxǟ^^΍Mɗ_*gϟҙaR3Vs `&lܸNkc'}pI}{t:tn)vc;(މ3O޾G3܎/{V BB`Ň`]kqx'V2I3xW̻6ޝ=fxggC}|ڦqR^m/UZbz(mٹ^-/:6k˅+phu78S.w8]z{D|8:c=z{cy/3ϘzylKߧ|<{|ss|oc<_uď`LO"&T<.k^<=k޽w|{NOwn.c'$3U}fҮkS?ޛuxoխ4i_ˏm*nὒTތw[^]mO=([6>#rC5v(ZިUezZaQ` Z'^+Vʥwj2vYoEh_}/*֏_>f_n|y0cxWu|yN+ks^+ SDBp5VXۤTv}q2f}ϒcʮ}۴~ 7ru~_?w/}±wIgk_ê)5ޖ]l|ŵ'NT_V*7p|\q2gTYvkREm;s B|J6~td/ .43S`fKRT{_;_evG.Z<@9p>ůYyE~,ӯy 8ߣFh΁ܣMT|;u\#=~åI;*ێO`}r{;N e| Oʜy$yL=DnQe&pW^.ztҸ-y9w"4١ܻzͫI^ͥQRUu:j}4Fq;Äƣ%ޟ.ytW4y𮵸F(.a~2s$d$T:*zGUj&|ڿtʝ.SX${w՘|jˉD'ߍY]m|]0[owx{jhyi[O^~ F>ُՓ#ju O tH[NH3GzV_/#_ r>2}U{ۣ6'ctN)V.pv=CgɶL}6oҮb^K;kkN mԾx^c7ףwkPN=W:M+IDYf4jYK"K+a,9px;Rjԩ&7pzOksFm<:)箋;.ggW}G fTʹ2d罹_5.ϗwg;ޠM 9>=՛|y&և7o{subݴxU )Wv^;zVT]?XVmX|jW9BKY;ש} Uz*;zⰜ$r {S*-+ӓd 'T{GѪ9z_-8;8ώ 3G ]ݻ F|FU;Ĭ˫6kn4oP˰ajW9u\^'r:uE+QޖwGZ_wVr_~ο ?|k{AR1bD3[ Y)! 7qb}Ӗ 2aU a:gƍrqenWT5]+:5uf:^tV{F/x?w\}BN<|mK:w?ʭ7ξQݺl:oti>=eY髹uru\{oX]~ 7nc>=:h]>u$g;~Tl{4nVGuFЗ6N=. -X7=/r.0Cjbf }S؛6 \@~s复\i y9v/ Ѥqp£7&3э?Z{i8ś#HeUկm|a;}*7xXU8ay琑}~TK8tP#3fKBHiԬԪWQz${owꙁs.)كs3,g8`۠ߙxi^sA zs:1<ޯ30 jM(8,c߹n}%t\9l=tp}oyY]*Yswb@u0φs~|"G7Bղ!'V=r9Gi\AgpqM+UoX[2xD/`i'}}$^[nxu-;){ }Icސv=J̑R^9 . jdټs I{w ݊̕rQu{}8iԪVK%k˝R? l>tL8r鳪7 1w=֧Igy(l5qMi8W{fuУGWmx5\@go׏T3ު-S.׶?29I5qGϪUVz;ڲYڴiAs}]a> eJ(sw'wú׶-v=sN.^{:yƷ`o`ǽ3I?:G gIHH͛Vtbb4nX|M?{6o޼b_Uj{͛VNt^l{9syMkjkw|a5ݏf13x['8)9вI̴-sm̾w_>69wzËwo-mykrpX#r~㕫*w>+Hw{ݿ1KWX>R>۶{l߳Q}%i83] j)QUK(֣#wK? #sew+KޖUyAso~H h$f9o}V*9:;6eu8y0n~ggϻ/]ydfPmTMͣmv0];MG}}0h_h֮][^~eEeF[;{]4g,u;?З@bwËw裱ş=Abr8nXAsS']:ۗ'N]Hη/+i}dw$"!HFO&IHuLoM7Lȭ6g/=\w'<~н'ԇǮK eIr,yfȺ+4^)g]wX_@to*nȰ])Hm:7 6hmnmt79t4͙up1 kfڲ3?e{n˯QK&ngb]hZlYi׮̙3o +|3{5|oxSM&^ f߼sMKbxZxA=KS`n 4%Jժgok ~,^?'gAD[q=uv/9@{}y::SgO&owY+FYF$6ھwR$Bb]7i,U)DJGɌEQJR8iϗA=)A}|:û{> yK=6pHшd2hT7 +_H^)j,[7_^aQ|Os֮_0QmZ%uӺ\E|`~žGeCk^9xE׫ytrt?ixogoܤtz6uCmO>3!_VϊׯoSMN6<@{-{{ogayL`,u?bz[9~QD)>/;xmׅmflݺu>vcӛ毹mw:87{ma]9ȱԾ>|,]@suV*ɘ ).l];hn>R:c%# %8 t:yCQ e}ٽk6 7w8'pkK%A1K%qL7[*Ta>uKjr1k貶nUR!$,FҪK-y̓=w emgG;7ws#dZ=5>h)f"xjwߕ{$wܪل3hѢRbE O?Fwo/}N9n[]>Nغf6gϛm;8]h~ӦMg4ms)9/m۵ɺjny:ysu~jն<)9| Ք բA:;3˸cV]RgPsu2|@)KF<}HD7fu/զ{[-c GwK7Q20~Q啦.^O?Y']-Դ4o5˪5`@R{ {սtGG!kٰa{g{ tRc3$М5^Py}0wrC(=#~×/ҽĞO QF ə2ً@{q0sY .жhFӷj噟ϾLX|5oHp~ujyc3why0u?Xr!9%yybjatƥ1{m{ ok5OwKr __c ح6*ͪɼjQw۬ڌ5W|֬ݲBd-nIpL>v1\l-E{owl;6tpuS?z)4iWG>w C[EZ+^sV:w5.^ߠ?aqyW6,UwvȂi)ks;#wԅOOתl\wnx0O<͟#~'//ZП#fϒo?M 6*n-y(z/ֱ'^ݜ;=0ļ7_ξY:!Ϟ'Fg|Ǿ-xR۠ގ?q m;/Cr[?G w/kgg\Zu<`r;X9̹ZgÞv8z+GNGKf+7 2,_NdV[ S!22i}ڹRyyy+):a~tٿh~>0nĻ͉`xIg.E1.\>ͱy"|8'9:}Hoddn)W?"M:ƺأgEJγ25}40c|J5>keͪM陹v MsLxJfe{ys8XٳoͮIoc?#FȞ、u3S\݉&/މ.^>'GޜA22f1ɪByf!Cw-6jPl:^o<9ޘ}{M5,n|3iߡQqͱ5lRK-P̣E ~e>c6g&W36XQ&M4{yuo9x8`ܛ nы"~M 9Yr,l:hDG|aL.*:zNXܪ\^U2YskAn=coވ?m|e^_`=0?koyHtmR9s欿&[/tRD/( ZHek>ٲyw( FKR̛:uޢ.&X!i'H7$,M:_5 qXHx\D|{D%U,V?xg^> ׉5/Wwʕu qv>Ҡt/7 zMkY*#՜[b+j򥒹:SnX.-IQW= ͧMu\|q&0~;wT_溒a׍kBMǛK8pГm4mo'\/r^ܽUL*kNj׫UXgyΝ;cayU{@{=̖N~=wwupry 簎~xo4r'>uj^EL\_EbΜYRvڡy΅ƛ}=gVZFs4?=6_ޛ 䔛 yrx/΂3Wr)ٱ{sl%jd]Z{ں}.Ӵ>WKҨM,Y&k6-rEϰV2zJ/y3~L>_].'q|yP 8?+Y|=p?>K굊^w ((J3N~C;HW~Qj5,/s'k?0y90,<_\7xG߿]nd5Ν;C!?17]*k֪&*W9H,9CqmFibߴ3{{ŭmԪ;~owW >&g3sǐc\[;k3q8? _DmpQqC<9OOoxm}{gsعɭ9@.;̎-gi+\lK_r{}KW,J4ԠTiTRϜ&{k5{` ze)Os_H]n4l^SxA֋#%ah|g8>;Z_wb>Eׂrikᒔ}V}EZSڍcK:%KbݰNM#FIJhc1f7ַ͊MYcN?\Sۼ-}I^tX S7r7Y/57fS/^`wz>]uqR?U7X_ys ϔ;u^yT_ ʓ9ky}_߬R]GGTK{^3N_)ᠢ΢sZX)X9=$O/g1,xn;iQw>"s+ojpB|ו?tT>RzÖ4`SҨsgSEsIlTwV+~XʽfzYj¶ܱKkYn|,cQߧlz߾}t_Yxbwu誎H<l{$:&R%ʍ㏻{}pkr;cG!9%3fO5kWqޞp0q[]JH>sf/6E?\x|"%&is-_:WK|^Nw/} }_M~>յp^xpmEA/>\_,tg^S3kb@_pCLZ{Dzmk~ߘ% -jHWTm$YvN+¤Dd=mtDb_8z/^ p>|7khKP/X zE֍ɤJKO1a(,&,X<_G!R::Ž c_YHvcӱĖԶ6߮x?rاAig=Pyy.1117z Ԗ[ó8_:vn+W?>.>J)U/刚0䤫fxpZ׀ VM~5r/NyyH-$OV5{}HĹgAa933",yÃ]B&S3&9{H TF5o'o؝rVW4e/n~afN9Vt~r:7g&K1dnP3Tsr+\Hت5f"%_Wmqt\jг$#')Hߴ^,a;y4gGKx'ҹT_}}[H`kRVe^HHT^y%#[1B綦dZK1Ays/ErIԇ#y;|eKZVtg2YR֮ϔ*g~׎}r1_\\~6LsdLJ7Hjcs/Oo+ `%>C}guF5+jWW/Q=}7a]w}-7Msyػ:$;^1_sc g̝ `ԵO38kg׊Y5 ϝs<<v[g2}TYpTŗ|?p}Qow0oRw0ެ붼ZQ8?{dqy@e .~W:ZsK}=gq.ޚz%/ʘiUnŊjVYdCE [⟊10`l6Rv32bB/2LM~tՐ/e{`k=5.L@C?[BpeK?A}s| /Y(3+3iQ<Ȼx$MGs?Oy<:DO[%N^1IbK2hd/r3 ,.#GYw_bvrw3Op}xɨ'Hه;o|;zK`ꢮAn ٴe$?cxڀ}^, ձ]īڰQ}Őr;f!5vͥzJRFE7lRao908p^~C[橯HLIl{ЀqVT򫯿^zI֮[bjK|Ul4}sg:scjۧMֵnjiwx=czoF?uʕsp.KS$ .Wkpi9@\Nv롶b^>?\{_å1**J*W,qqqRpa߻s.|d=:Y~?x3:?GwJ~X'J!:a՚5*sdFRƎV=<%u8!KV͔)3G\Vn{)Pe9frk>>zu4/^ /Q,2˯Pe5/(5 Xt%l [n'~_;zfFp&c-Q.z?/~i0/}OῃyEծ}[y zƯj{7?gqp{loG<=ݜ:0iҲE+y([?sʻ]UH\Yus?u؀kfL9j=ur JRPlXB=-떒Iݤ|š/RR"iy&O?1 jo縯p٧$Mͤ^h +(wXOHĮʇ/[JGQdBj:OpD]?.TyU[dd,pX_&-յ|Y;hܞr䝈5~wguϓ߳{̟75{ovν֠Yj5yMrxԋ)wWF {,/_#tHI?>¹d=|b3soM8VI[N; `:eH ÏƏ=5y9O|6)soy||tg ?6]bccs^l9qΩ'Ink`xmv~)'g3 k{6iO2wpY_ ͘l}GuOޥgt0uÛ-tH.%˖vf{ZثjoAjT zYeL eb_RQ/oq{wSi)A1/JW'ZJAJԇ_g;Ȑ)Ӧ93>D"^%w\zE{ify+nZ;vS7l |Ά7su|e[obs·\ ?9T/wfS>gyp|6'>닃w{uPM9';ϭ=ӕӇo};Y4ToX޶-Ko9?' ~dp=W 1_/r-"E>ލ?HԳWQC M#{Xw6[zܽX=#g^/֭׊Ϝ=e:w^˞gwk.^7~ άq>xq_LGޕ+q*iѱS={ߙ-4cY-6{0!gKߦ20yJ>,ϼߝ7ÙEb2ҤC]ߖH$ٝ?=tVB30ŏ؇Fmcyeޚw=k̝)毕E"OOOl{_`E|=Z׹8=f 0SjNXy=Rs.Pr䱰+\+r[{C =ʕ_s.>^fmXGnLS&hأolQgꂅgT豃.ޚv?qlظFw^|\zAK9~̞3]R$=Xg^]qJ9 &9|@]ޚCtnK2nX5Ƿ)'>>>+3:;X@\#5[zNp.Sאh\WMs.$4؉ǃ˽qzD2j`I3Mm\d0N" k&mIƢ4?%IU_lՌz}!}>sVN>%woœu:oT Q͢d2٬}5pG/5jXK2jb?g3Οrz u_buz3gɰქWnZskШԩ[]9϶ߥjmg4;`f511{Z۠5wE9E=^ '^䜚3']t|nz6gNS._,-z%?qIIJITO>w{_90ŝy6G<%19,jjԤq. l|?jC=Ex6:'|y>{mug/ YU3r_6sߍDz8ӹ>,|z..Zç;NQ Qh?5T8>KH+RRqF#}_Xc_O*o}LX't52 ~MC%oܹV0QWz n(: ^yv'M+G>(AM.iI긙Z5ni)Eso>[˴2w,}.'!v$ ; +{/>Xz߹neQURŏo/޸/Vy'lC{U{?^MIVj Mk7/0$ s:]Fne7PO5RFٳ稇S3'֨HO rD\ ˫yK7=xbal;8w7~ Q3v#6K?otI 34zBʸ}A.NWYEަ0ë\/&՗_읥͒P͍~Bm΅4Յ_M6k]8MaÇ;;TLNO9Nң9= qK8r:n)ɽu <  vPg֫׉9TTHunhV`˩C܌y㱇 ^oǮc5ַ͍dmW}tV9jqDWeZ?#_p4c&ZYɲL~.f~j?}LJ~' R]L4k%.ߥOs)3oc''$(EsKd\1ܽO6MfLw2kLeo'̃sy>toC0*O-x翀S7Z`Լs4s^[mlCd%f6]vm~}my?M>VοZr`A.n"uא[EyQپ}d획bRyԖ)~tPW86#]mS&uC@)gw+aczȸC5SŤXH^)X =jtQD,}arvӜGWZE](1>u@kOOgq7[l=>a; ֹne۶mVRJX/*?G[+^Hgٹ[Zv'D7 l{[C9=xOoX'>G mCM-gypqEKZ9?FOO$p>;r`3 `Hؿ8}~};,y>ټ0wX<>|+J>=ԿرsNلJzrX0|[f{M_YQ Ə/TӼ\L Si׾u ▖Z:?_\͹oLpM[E/)˗sɢ+d¥'8糇ǿ5m%i@%2y gʤIi7o:%#_-^^"`}ȰҾ[3߽U!tB +#FX=y$%'N$OiFE>+mtBL6Ny-MtVվϚ=x7>Ч-og9٦y~0}Vr o`tgsȽNVYO֐Vz6價FM֖;|7xq`~RzR̵kUv-'=9uN}5h>hMVlhoѻx'5n#9wľǁyp>~rUɾCd1/rNQopmx}3 jذ!<1gwY-A\guz 9^ƙ g7;v7kTYo7_G<-?>Ǐdc}J+t2eUysj .7O9gϞtX|DiٹݣwO *$|$T $z4Uݜ7<<<I~#H^M%ja>{tWc2nHjN$R'2er/|kֳݡ8{<],t{oދw>Gp]Ưۡ \x@k^=}-Z׻Ȳs3\/b975:<e稗s=GF. 6K_g{ZK.fwSKݵ*msvqp} xW߽}~~S.$'e50?߈?q7иiO#3;G3)ab+E@YA][}֕|csgs9 ~AJ<,=ilΦ.&k3Sx6x>K:h!]zr5GͭE:vh@8ٌd0^~)Rn)Gz,Zs8> i*LJ nkMg<@'C~ [C͛Q3i8Yi߫\vy/eu׀{ y섕Ygg:{U i0`|?O'?Z^jiLϸ[nLhu= ~'NJbݢ]YkwigΈXS:Wa=؉ruZ=d=V>oϾmf}GIpWwJkQfhܠ֗&w]:>AMrKF/ɓQSb$4[k͛>^c>q*ۙީ&lKE۞؝yN ǃy8ѥs읱`5f|S;4m=}f.8foG_az:3NDЏOj^njṚϝ^]LO#KV,ȡSϡTbl̯- k{`OrٟOӜ;͚=í=>[U]{͜Yf]_QϯN~.~5aݻ[ 獧>}n'H| rg^h;|q?33n{\H.@W뾯߉=u᯿pvOY{wT/kn y:Ş_ʺbzw8,nvf)qi<ݥwfF%>xZ-3oPU]뾻yei11FcILwdܔt0á^7TY^zb}Z_^Bye}߄tצ1=^io[f5+h42r VqEpƑ5uuH{Tõ/im=z~Buv|C$(fE$<- Im]ۗhmeUv:U+W}|뵞߈`7yٛ{/Ƶuw`X{Ჷ[n|Gbi^+nFO^wny{=jC0.oL-vmk*+~i{duU1M&RVS@7{̫,RN$/)y9zk6y~+foУ}O ͯOoNݬ92s)*u}qU>{;g4 +~k->dIdz2}k' ^Yp Oκ"7PW Þn/>߃<>HsX?y┮cUد=3 6S'|pSO_}MlQWl5k.>Y;5'fbNyT/yst#1NZi g/q:݋wtzg1;xq<6=¹{\.P'G? =:w[^-wk<3G [L_b-6ċy6 L ߭6)O\:63z육hB9 h┙2gaQ̐UE~1_OU*fΈ9'G ~߅=e՚o{I}y|3Wl[xu]u1{nx7]hc!v:|x񻉵/'M-v+zX&z 7Xg^3i`݋wֽbcsK>X/Sf >I/jOL2.7[k`7jL`26w…W,Xv ҵݪۉeOʪjW-Z(Vk} ]k~_nYA֭ݤBnn->tjm1 y[S~ݘh'X7/7|Gb@#g ;^Gmip?ɞȎݛeJxJ\w򫲬qL:Nj*r^B\4a{;,(t2KRI ye qd 0Ǿ{v HEl={rפvahmx};_Un-yzTc[kfz%v SzlW_=sBq}J9P3׉)f<%G.gy_z4'`+w#8u #"啕.n-׿ҕ:l%UYҰR?D|TF**fj1s 'aqO(|s'IVר.z3A+޸b/_J6oܦqlלo!bXx1{{-nO]PC-y;l}0g۶kMm÷W#'+^O?HFR|7X\ dB(6#Wg2xȝ8DVoneel:+Wf;_8'Of:^\/h)n>fasz>sn_X*34^Ⲝ[UMя:sߔ:g7=v}Y'X?\u;9s/YsG߱)G Y6ֽ{ ׂ(jilepA yZl}z܍__mv#N;jmwt;q:;~C4߾wρkN<j:kNasj6ov~ۗVAG++KdXn).,WpvYL&w}=daWS]+uRx?'lO| k$jx y>Z_pz{{_[=v>:߰' /p?PϿyeλ{_w>Uy׭1nOoX3EM,JƩ}H%>xUӰge*v^i),ΕcFO¹eZx)(#r7Y>)Ȼ%)*$3${[W_W2X^x^>rʘܑa9{䓏F++/V.1iǡ>?BWZy>r Os}+V5} W>g!c3qqqZ86CCCuX%W矗mj '>ƇĦd=IS孟;vqMb)ϥypbg%`Dļ !ήERX"㟔;Z'hu1kT+2j|WR]Xdq+U`޶X mNyyׁbz`>ˋyl|=MlW޽x/.;;ΎxW6v;gΝf(o"S;]Ǿ'Jy\#ݞqI~,Yv29xt-T}̛^Hɒ_:Vf9{!(G]$'Ӽ?_|_Ⱦ#{eJQL.(|ʇ|dQl5i8䃫y~3g_޾}o|uZV`Gi .z3K%>Dؘ%kw` ^#}M'0OLFOH:KۥvED8{Eja}V+Ϟ7]V9;~E;;XF=s^V u8{a߮Q` gqow1k"x}xm'w;ʹRt!O!z]QEw?iU0[ʻa"9&CrwP,_ f鬁2x52d57 sz>'L>J^޽QN=R.6H_(#eNe{QݝO~9nL)smG'9[C]}W1nbXȕVy+zq^e-nz:tǟz)Z?QNަ7,㫶5n:Ջw:2֙^z`" ͖ԡ5⛪cv!]w߮: ~^r> q2;P9F8%RWW1:|w/9/)YlxՔZ6Cp N@ޛ:kg{^_Ip{V_vz}gtHᬩ2xdrjII y|ud|l/# 6{w>v`'W痌q 'ɉse2|`݇ʡ/>C&Mq T1wl޺Ir'nMՏxkuL+P15.Xkr<͔2nhI5~[ی9 XS֯r:3Wv,k74HEUtt {Nyo8r~e2wl3g.+啲`~ο\PȨ-f kE'ꆨ$@})k_?xAak,[=t3׳^s<9^]Msͽ>9so(YGNy$1fK͑b\vk=k~\rN҆$_kV뾩T{`u5qG*/3CO*9C2p_xnbL*R- zVd|OySfv(gJڈ$Y\9Jg3eOV_Us̙)ΌA_܃xj>wJfxg$k Nτt[Ї+~]av8b1ԹsLk,oiz}_vlνq޹QvXͭp5}^[?cMZ^{M8w¼ kMO>lՊu\,ɗ6SGŷefdͅٳg˼2b<00"ș߉:B9M3컓ϰ߰:79gOAsm̧=3#ЯoN{m@^]Y{zQWkအڕ%r1 ^O}^Vo\&)9bo9?[N9a%3{rye4Lv밅s3%CWws%oV{j󞺟8!re4s6Gl);l]>" Ƞa$gX78{Um+^:Yûp izZ_nºɲ|Ŗx/JypA?jcCb}5w~5`r/V3?j>l @=w`ljs__^V˲Ұleb^!aeW0Ns3 uJ92tOj}=pLpu89k=D<{Uur<05թS' ֏d|}><>j9{^Xb ^;c_lsGtA$+w`(1pu-KRfwdqw06)r(x;9]pXJӆh kߜxm=wi_~θ|ӳ]+9av;Rpg O3&ʑWԻ#bj(\\(|?_{FjL̿ybI1g"!Dl^/V$g1ylQlfH 1}c4ns{k Oa:1 \&Fg/_z~˩-dZ]Rz 6cǣ3ߍbzmvc(?G)5/&[ZqoT~' ;F97gۛX}7gp߰n|?㓧kHbz"J8֬wk7+L$ڴ}yvrMzطSE~59/x&^߲&W猝1yCeGJZK#nyϴ4NOl̿{Ά?+I fy˝No9|s5XW{ pK#m:>8O9r߫}pL+G9v0u]c]l\lX|zcݱNY`=P{No*`we3C IY2Du;p*/ V^a(n}jTn1?yp̀s圸v(pZlc?DZzz̮|s{/9~\N7>'%6ڝr٘KnmtiYmdʳ卷q\2GFhʆ qWۃFHƘ~2rr(HfN_1㝍;)Y%;w_FNN)i2fj_gE ~M~ZӿV=I q}y ՟ם?yaD2~hz]_:u|+ 2cu SM}5?31??_B ll^m<_݂;ԿݿgQ_'Vb:^s'VuX_B?:= V8Qez +KfV)1SJf/x7lp}_R(  |u6MrA{ZvkoҤI+S9";wV,oo<:kc3{ý>9]-= pyV{Wo9Kޑӯ8e9s)e9~ڝˉRZ9C>"g)ѝ1)9.NFLLr(Cs0 #󜞟(' hz'Tÿx?>Wo| Γ]HWy9}{i}h $ TW5r c)7UָG>uƇw8yt;Mi-˭^V=BfYoƍk;>59f=++U.r gegqځ57:Xn5qz ܹϚ%ʉcy'^WN0zs?uxڿvw+֏>(mۃ$.>FuPͿ(R[n>S`BK4-wi=877zl|9/Os wX+G_ٯkt_Iya~¥3tܻv(%S$iXtK6d>)Vaz6d&AG&}?bBd8ݍ/_]?_}yR)'ׂ&~28Qӈ!zSkء1 =%>fȎ=gݾqRsW07/8!gϼgN[~cGm3HOu6'8þd)9gԠkiΙG0\WWz~Ȟ8f{`gYeu`ʕ_~78/Ӝ9-[wMLZ{)**R~j;^s+-}5B3Ƽ"װ/b~!Nڦ+dqcb=*=}th{h|I.Cƻr2l|_ |*'e؄yw9$s;DZ)2cRLcv}%0GW> 뷬$} ٵw=VkaڛgЉ=22'Cާ'V>>aY$3t;v;\Xk|jdfw:5 3suI(Ě3ޯ`^t竫|: UgN+ h6 ~/.Ғ2)S- Uv 9isɝw[ߧ;vn'cu}g̀́y{^z:`g+{7 ܷx7{f[ag3gΔHNTyZ9w%9t?YK+pzጜ8}X{И=ٹo }Q2#.% C%vrJTw~5)eRXNzmb̽زkdd*73s=rb\xNg갮tNU+OwX?$}zl! yka7zl8./{1o 1b]SV\R5ps P`,>1Fկj u'lV 烏d^# U6u`O?53!=+Li^Ϝ-g͓R_J}*ٺeg|e32|Hy"=rXV][۷WGZ3+8 !1{`:ދwQ111E&#ۜO?F{Mf+ֱUN!7%1=V9HqI/1VyQrN)wϝ&N:3p鼜z.+)'%0(\w}[wps~yŰ[Q#:eMt k61lp.x<}ԻwW&3Nz%#Sc<\Yw/߆QaσZ_x TOGt̛s; >1@7c;h{hlͻqBi,kXy=x֛L?x;=:w9^Co{`8OPsN]{w ̜1CC ~n-1/JT|'g×ʱm2PwԞd|)Lr}h$;|ev!=^QU㗴1~{K28 f>6/s6.I!능OR77l_!_zEv,!9ov?sZ9vE7dϮcwwn~9t|EvVǤ?)SJ{+)O>8£;kF9>e Ȍʥ%~{bwJIF)M#7)#=۟# /ƽ8G8?2.HkvsڈKt@y唼ګϙ2L3(9&#=S~Y>g3- @i9\9sx'c[3о3o>}wPg05{L[ ?xr·L$*&X"zwxu`}Ɋr NF=#K֔uO}^eqm}o7#I#s$^vNvHjvI. #a?$ rn ½v qϞ;/Ip3i D:rT~ثrqgן<N4Z;q9cu =vHgEϞ;W\q#eDP=NΛTE?6;f+t. ѣ{~oN`}…xpp}>D'vt=x'dZkMgddO|8YoF|'^kg^WZzy|vVSk`ܸo9\?wΗeۛm<97II1uLtߥ~=GWk>AԎ&mb AmjlؽDF&H>In? :J%:%},qD= Fx Ixߜo~+@{};'}]E&(>-Jb"uF%51ӿQgs!~KVI$j#44[$ǎS9p +A,\#n'ަߍ5%䚩7]ÏtcZsB  몰AW1b}"Cw03nݺ ޱt;z܃yeee~|7nxk:;_1q?&9y:S^:j"GCL]:8`qyLgISSA'^Vc 8wlilQjmtScbb^ ﹹ;6='0{`_X}s'; ~^@{ / N<'7މF>hAL_Ȏ/osawN'J^1^Jl/٣G緫>ٲuƀw +7.QұS28;AW:ܯt{LJ~}e!2;Hܰ1I^GdJ IxRzjMev Q=l[Frf YFt^)OKbnIyͻWʴ\lrPദ~p}RV]s5~̲CFOuKT##Zawbd'^ޱ;y-σetxpHg Bm)}7g?MM-5v&^w`}LoMhNN>^im- 0vN\ǩ6#ޫ<{磳~Aj#@ cãϭ?k\py^ك?a/oygoݱEcor~c )mt37s{|{h^8|DbFMHWq-'F;@m_a}w܇'=Gv$&%0_5! o$=jh{ރs/H 9)M6l_)Iծ?Z}G^9 k׾fY:Ks)4<[VlϨ0:F~;/ךGr0ǜosʼnG-|vlyFM*g]{G&F=3\㯃kt!CE*xGZ>}uFcû|8X7+nc׃yyp[l> ~Z$ugwY}:[=CyW[wt;;V`>a˵#7ӏ}l oJר56LT=ܞ~P)JpG{Գcٰ^k_ }XS:K㦅RX>Fp?;>i>- MyX">t k?P ŗr> mo'{.s7yD=%}!T&hq/<:Y^P7CBsc2cX9xlۇۿL֙ 𰧍 m{W˞{56Vz#zF\ԖOmɞO99bSV4sL}hXw5`\?YcEm)1u/Mbb{0Onypщq.z;b|/}6섙>\j˟yE_"^ w/'1koٹV&O }Tr2UwN|n݆ڗrsJ]e{.^/Z#e45qo-NjX=aދ@_W{ 2}m$vhG} xQ ڭ^ɞ#른|}T+0_;YPMgN.~߱k9vTc?.z` <-}SxG?U?S{:kl߳Qv;w^Ǔƚ~?WjN6 o-utcƎ&t Ái+'ꃃ]/߇aދ}6rm^'E $4! $ kb{egL[M:^׃}ȒseѪ"uty@B-`[a?8AG$jMB2)"/}JA'Z&k:ukk\&|wuV@Nm;}u)#OGe5l9bu9rvSo='PW.C7u98x}%{vvַylz%\<–&Il$wH}X>\ .E^Kj%cXG3Asw^wiw~^P_kG'nܽK_QRGN Iyy9{;<9q ^C>Cyat{ WVl] 92wk?}jٵo>qJHߧ@swmeiJ‰N~7[NbĒWu,Cq߾?J 6N rt}H`[ϞƯ@-v /ޣxý^i*/p=S?U=G;AO)ҟ}Ge>!%8wk-fk 4k@i $뷬V׭c}m6̖ZGѵ}),.:f& ^5H='";un>9xM;}G#? t#:Ǎ=_vpnܢX~v:7b|*GoxR;V0oy:wûO⃠គg{x;u_9=sA͌Nl‘ Vឣ׶A|DigzROMۜmZkNKؓ2nY^>fΛ91eRL9%C`)-$dO[(%+!c}*=W %nߌ |H%М\oK}wρVv:Uz-ݒn2K\YB":I2z0jœSăl| ~g,^@<>q1v}3擘ؕwFQKӟď?(Ǻ6>܍p]崃7Ր'?cSĵ>qpy96WjN|`^Su ZKnꈹf6)_7}k8wNGB IVTfF_y481gKFMLUޕ6Ȭy>(9YRb<='+A}@޻&=tK|\'=ǻýa7{q?3x:ts߻{7t=,>uPRPUI/IN2cTٹT9__Yi;y9GKwg[E w1_|ejf͏,s6jaIjo~58:ccz)?XmՕXv;{ lX0乱'XGzs[oP9Α8Asx7_3bwVg<瀽8_!4)ǐgb|6}1Ig+47<o| ~Z *Ғ:z9Ұbfn^]C{G t.9v^[~ H.(oʊuj0y{kdi.ANlgwB-tۍ;7Pˆ@‰H,F(C򊲴NL}ʏ~NO32dD~oηV_/]=8WI'}c;vTK։qĮļ{l{Ȱy;'{LAx}>ݷǼU/uXKĂWיhի6mnh~qV"e9rs 5Ka2fo/υ`#=oԻnF|-I{oQvCtf2w"/ED?,yRV[ 2zp53gNϿW]=nsn)+AʍIrg??5|RS ~K/~y㏯j,u<5uY'O-u*䩈iSGOkXXs0iy:hx'?b=yak曳|Ӣ9_){ "VSd{JU,iE}aɒZ7L-QaH^_{ɂ"YkeEFiX=_f$49ICVl/_3K!/XR5I&KP;=ZHĠw)ũ}~t-Ih=(7?,Hv |^K'el FwYO3{{* f+]G\ 玔I !fg):O~v~k'Ji[A1O{<xi퍥׆#:~Tߑffm>$v1XgGuuc ޱ뽘G{y7Vc}búl)b~aM,QW-\*U5laL 1K%mD_)v69:j(_^QDVnX(O/}13+;)y>=S[HxA:ǺZ*X!ד;n([;}Tڷh|/w Jrt}q):g͖Rn h|d획~fYv4jRWJ2հ~}ѧ?|?/BX[ϴ{L:v{^y&Oo=`2ĽCZC.s-"~oo1:˷ycksblpޱxG ׋߁uùٛ7[ˇg{^ 67{^Y|E>=_NW.|nҦ/?L+'KI.[nL/,}ºҰB,Lss%&!aG ubrNm0mN0 x5m|u;QX rρn)3 OHmj(oZhIxAxJ3H]ml޸M6l,6+%3'R"lݽ^^㢼gӿ.?ٯTo>| SRI$)wzmyimڽgF%Núƒww-g9|qߚMb~a7aujKJ=WΓ)E#[a胤'nIWEu2zj{Y~7yӥgd'yU`i~3<pxtaoi)-4V@)RteRV^S(6IlouNO˨AҰd5gRt$ q}=;8N޻ ԟoa_s{_=8ԁ͝;1Nost\hϋjw2~SG} yhjLĦ̎7{xú́zN_ys^>Px|9^{}}?Ҳ_U&3fMWŐP Iչ}`Fs5}hgqgE:kRz(BH6㾥ĞF/=T=R2\jϔ^/i2|u d:ǮV{R{M=Mke:ជt#;¥~|KMu X/wpNLqb\1)Wݽ1`WexOOOWL {:87_ދy/es>l{/m_s=36ܺD>΂\iyBYPY#Uյ2Hkd/d;1*1o8l'wu5!Zm%ĵZztB{دܒTߢܢ~w-I5g#VO\\jONC'r7:9DI6[%K/Ukh';zB{Fk2cue:7w?wz f'_͑JpNڰ,_tәaKc;5}`#{zcw<{}yüצoΞӹ<^ѣsZ)`7WȱC5^KJY2_Θ(}S'%ehw[5}cd+]/J05 Mv|NClSnIn1=-no9g@{ɍh=E%klYS$4%~Qϑ%,Wn.aOɌ|ˤ׊T} I奞wːq}n{ 9~/zV??~qfu~q@n4MvQdlhYX]G:zHN8&bC.JDPADAbHpLGBvAmS؋Iyc~rxw3y!;/B^ۛ;wgCwvsҳw =Sg$}X*.U ]bH݋fI2᫦f+)s%)=ɝk{gwJji\kFW'nƭv#ַ7íX\/3̘rWXmscCd@~97 LΒ>{a\:{eK87JnkWXj!w^עEKiu6w-򽦥{}۽-{ݾsϷ;}/,XZ}krw˟I6;[N^~˖wX.wUin5;;t6=hq{޽[hZu %&n܍5l8 č==L wwjx_/ohwo1ٷ$$If0!vh5*#v*:V l ` 065m/ 23p $$If0!vh5$5#v$#v:V l ``065 5 / 23p$$If0!vh5*#v*:V l  06,5m/ 23p $$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5$5#v$#v:V l! 06,5 5 / 23p$$If0!vh5*#v*:V l ` 06,5m/ 23p $$If0!vh5$5#v$#v:V l ``06,5 5 / 23p$$If0!vh5*#v*:V l  06,5m/ 23p $$If0!vh5$5#v$#v:V l 065 5 / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5$5#v$#v:V l' 06,5 5 / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / 23p$$If0!vh5*#v*:V l  ` 06,5m/ 23p $$If0!vh5$5#v$#v:V l ``06,5 5 / 23p$$If0!vh5*#v*:V l  06,5m/ 23p $$If0!vh5$5#v$#v:V l 065 5 / / 23p$$If0!vh5$5#v$#v:V l 06,5 5 / / 23p$$If0!vh5*#v*:V l ` 06,5m/ 23p $$If0!vh5$5#v$#v:V l ``06,5 5 / 23p$$If0!vh5*#v*:V l  06,5m/ 23p $$If0!vh5$5#v$#v:V l 065 5 / 23p$$If0!vh5$5#v$#v:V l 065 5 / 23p$$If0!vh5*#v*:V l ` 065m/ 23p $$If0!vh5*#v*:V l ` 065m/ 23p $$If0!vh5$5#v$#v:V l ``065 5 / 23p$$If0!vh5$5#v$#v:V l ``065 5 / 23p$$If0!vh5$5#v$#v:V l ``065 5 / 23p$$If0!vh5$5#v$#v:V l ``065 5 / 23p$$If0!vh5*#v*:V l  065m/ 23p $$If0!vh5$5#v$#v:V l 065 5 / 23p$$If0!vh5$5#v$#v:V l 065 5 / 23p$$If0!vh5$5#v$#v:V l 065 5 / 23p$$If0!vh5$5#v$#v:V l 065 5 / 23p$$If0!vh5$5#v$#v:V l 065 5 / 23p$$If0!vh5*#v*:V l ` 065m/ 23p $$If0!vh5*#v*:V l ` 065m/ 23p $$If0!vh5$5#v$#v:V l ``065 5 / 23p@`@ QNormalCJ_HaJmH sH tH <`< Q Heading 1$@&5CJ$>`> Q Heading 2$@& 5>*\DAD Default Paragraph FontRi@R  Table Normal4 l4a (k(No List\^`\ Q Normal (Web)dd[$\$B*OJPJQJ^Jph8`8 QHeader  !aJLB`L Q Body Text-DM & 6CJaJP`" Q Body Text 2U P8p@ P !$`'0*-/2p5@8;=@CPF ICJaJo2 QBlock Quotationt$d$d %d &d 'd -DM N O P Q ]^@CJOJ QJ j)f.f\fff!z!z!z!z!z!z!z!z! z! z! z! z! z!z!z!z!z!z!z!z!z!z!z!z!z &j).5e=ELT[ bNi;qt1zs[o<+. $    /k5i +,%|["T=z,L<`D\ r " # N O )       / Gz ;l,\+e#NG 9k6e!N YGu5h!R~Dn 7c:eIt!Oz - ] !:!d!!!!"?"g""""#=#n####$B$m$$$$%H%p%%%&6&i&&&&'H'p'''()(W(((()?)g)j)v)))))))'*U****+<+l++++,C,q,,,,#-M----.1.[..... /6/g////&0U0000001G1z111262Z2i2|22222233'3=3Q3e3q33334*4R4h4i4|4444445C5g5555 6P6c6666667#757H7T77778C8r8888#939e99999 ::>:W:c::::: ;8;f;;;;'<W<<<<<<="=5=U=e=q====>>%>5>d>>>> ??@?V?w??????-@U@@@@ A=AlAAAA BFBwBBBCCGCxCCCCC D9DjDDDDEFEtEEEEE FOF}FFFFFFGG.G:GjGGGG!HRH}HHHI6IcInI|IIIJJ)J>JRJbJnJJJJJK3KFKdKoKKKKK L3LQLbLLLLLLMM0MBMOMyMMMN1NbNNNNOFOcOOOOPDPuPPPPPPQQ)Q;QGQpQQQQRRARNR]RoR|RRRS4SfSSSSTTT.T^TTTTTUJUtUUUU!VFVSVVVVVVVVW9WEWvWWWWWWW XXBXsXXXX'Y;YvYYYYYZ.ZCZUZhZZZZZ[[#[<[T[z[[[[\#\0\?\a\q\}\\\\]]6]O]e]q]]]]^<^l^^^^^^^_H_s____ ``,`C`\`s`````a;amaaaa b8b9bHbkbubbbc0cXccccd(dKd^dpdddddeReeeee'fKfwfffffg;gGguggggg hh.h>hOh\hhhhhi&i;iNi_iqiiiiij/j\jjjkj~jjjk2kakkkklHlsllllllm(mRmmmmmnCnDn^nnnno>ojoooop%pMp|pppq;qjqqqqrHr]rrrrr(sYsssstt:tOtnt}t~ttttttttttttttttttttuQuuuuuuuuuv)v@vSviv~vvww*x+x8x:xExGx]xexnxxxyy+y-yKy0z1z`zbz~zzzzzz {|||||||||||}}}3~4~A~C~h~~~~~+4&).1Łȁւׂ(25̃׃ڃτąmn|efKLY[gs89FHTlΉЉ҉$&:OdyŋƋNjȋɋ "6LatՌ׌ٌی"#Z[mp͍ -956DPr’Β*~ŕȕ#.HIVvjklmpWXqל;Xrڝ1;Pfgz0*0*t0*0*0*0*0*0*20*t0*t0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*Z0*0*0*0*0*0*0*0*0*0*0*0*0*0*v:0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*V0*0*4 0*,0*m0*m0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*0*0*0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*0*0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*u0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*u0*u0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*u0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*0*s0*s0*s0*s0*0*s0*s0*0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*0*s0*s0*s0*s0*s0*0*s0*s0*s0*0*s0*s0*s0*0*s0*s0*s0*0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*0*0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*0*s0*s0*s0*s0*s0*s0*s0*0*0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*s0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*% 0*% 0*ʎʎ% % % % % % % % % % % % % % HT30*% % % % % % % % % % \% % % % % % % % % % % % Pv$0*% % % % % % % % % \0*% % % % % % A% % % % 4% % % % % % % % % N % % % % % % % % % % 4 % % % B% % % % % % N0*?% % % % % % % 0*% % % % % % % % % % % \% % % % % % % % % % % u(0*6\% % % % % % % % % % % % % % % u(0*% % % % % % % % % % % % % % % % % % ,0*0*4 % % % % % % % % % 4% % % ^ % % % ur 0*ʎʎ% % % % % A% % % % % A% % % % 4% % J% % % % % % % % % 340*ʎʎ0*% p' % % % % % % % % % % % % % % % % % % % % % % % % 4!6k k V[Z[v:[ +,%|["T=z,L<`D\ r " # N O )       / Gz ;l,\+e#NG 9k6e!N YGu5h!R~Dn 7c:eIt!Oz - ] !:!d!!!!"?"g""""#=#n####$B$m$$$$%H%p%%%&6&i&&&&'H'p'''()(W(((()?)g)h)i)j)v)))))))'*U****+<+l++++,C,q,,,,#-M----.1.[..... /6/g////&0U0000001G1z111262Z2i2|22222233'3=3Q3e3q33334*4R4h4i4|4444445C5g5555 6P6c6666667#757H7T77778C8r8888#939e99999 ::>:W:c::::: ;8;f;;;;'<W<<<<<<="=5=U=e=q====>>%>5>d>>>> ??@?V?w??????-@U@@@@ A=AlAAAA BFBwBBBCCGCxCCCCC D9DjDDDDEFEtEEEEE FOF}FFFFFFGG.G:GjGGGG!HRH}HHHI6IcInI|IIIJJ)J>JRJbJnJJJJJK3KFKdKoKKKKK L3LQLbLLLLLLMM0MBMOMyMMMN1NbNNNNOFOcOOOOPDPuPPPPPPQQ)Q;QGQpQQQQRRARNR]RoR|RRRS4SfSSSSTTT.T^TTTTTUJUtUUUU!VFVSVVVVVVVVW9WEWvWWWWWWW XXBXsXXXX'Y;YvYYYYYZ.ZCZUZhZZZZZ[[#[<[T[z[[[[\#\0\?\a\q\}\\\\]]6]O]e]q]]]]^<^l^^^^^^^_H_s____ ``,`C`\`s`````a;amaaaa b8b9bHbkbubbbc0cXccccd(dKd^dpdddddeReeeee'fKfwfffffg;gGguggggg hh.h>hOh\hhhhhi&i;iNi_iqiiiiij/j\jjjkj~jjjk2kakkkklHlsllllllm(mRmmmmmnCnDn^nnnno>ojoooop%pMp|pppq;qjqqqqrHr]rrrrr(sYsssstt:tOtnt}t~ttttttttttttttttttttuQuuuuuuuuuv)v@vSviv~vvww*x+x8x:xExGx]xexnxxxyy+y-yKy0z1z`zbz~zzzzzz {|||||||||||}}}3~4~A~C~h~~~~~+4&).1Łȁւׂ(25̃׃ڃτąmn|efKLY[gs89FHTlΉЉ҉$&:OdyŋƋNjȋɋ "6LatՌ׌ٌی"#Z[mp͍ -956DPr’Β*~ŕȕ#.HIVvjklmnpWXqל;Xrڝ1;Pfghyz00000000000000 0 0 0 0 0 0 0 0 0 0  0  0  0  0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0! 0" 0# 0$ 0% 0&I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00I00@0 I00I00I00I00I00I00I00I00I00I00I00I00I00I00@0 I00@0 I00I00I00I00I00I00I00I00I00I00@0 I00I00I00I00@0 I0 0I0 0I0 0I0 0I0 0I0 0I0 0I0 0I0 0I0 0@0 I0 0@0 I00I00I00I00I00I00I00I00I00@0 I00@0 I00I00I00I00I00I00@0 I00I00I00I00I00@0 I00I00I00I00@0 I00I00I00I00@0 I00I00I00I00@0 I00I00@0 I00I00I00I00@0 I0 0I0 0I0 0I0 0@0 I0"0I0"0I0"0@0 I0$0I0$0I0$0I0$0@0 I0&0I0&0@0 I0(0I0(0I0(0I0(0I0(0I0(0@0 I0*0@0 I0,0I0,0I0,0I0,0I0,0I0,0I0,0I0,0@0 I0.0@0 I000I000I000I000I000I000I000I000I000I000I000@0 I020I020I020I020I020I020I020I020I020I020I020@0 I040@0 I060I060I060I060I060I060I060I060I060I060I060I060I060I060I060@0 I080@0 I0:0I0:0I0:0I0:0I0:0I0:0I0:0I0:0@0 I0<0I0<0I0<0I0<0I0<0I0<0I0<0I0<0I0<0I0<0@0 I0>0@0 I0@0@0 I0B0I0B0I0B0I0B0I0B0@0 I0D0I0D0I0D0I0D0I0D0@0 I0F0I0F0I0F0I0F0@0 I0H0I0H0I0H0@0 I0J0@0 I0L0I0L0I0L0I0L0I0L0I0L0@0 I0N0I0N0I0N0I0N0I0N0I0N0@0 I0P0I0P0I0P0I0P0I0P0@0 I0R0I0R0I0R0@0 I0T0I0T0I0T0I0T0I0T0I0T0I0T0I0T0I0T0@0 I0V0I0V0@0 I0X0@0 I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0I0Z0@0 I0]0I0]0I00@0@0I0I0I0I0I00 +,%|["T=z,L<`D\ r " # N O )       / Gz ;l,\+e#NG 9k6e!N YGu5h!R~Dn 7c:eIt!Oz - ] !:!d!!!!"?"g""""#=#n####$B$m$$$$%H%p%%%&6&i&&&&'H'p'''()(W(((()?)g)h)i)j)v)))))))'*U****+<+l++++,C,q,,,,#-M----.1.[..... /6/g////&0U0000001G1z111262Z2i2|22222233'3=3Q3e3q33334*4R4h4i4|4444445C5g5555 6P6c6666667#757H7T77778C8r8888#939e99999 ::>:W:c::::: ;8;f;;;;'<W<<<<<<="=5=U=e=q====>>%>5>d>>>> ??@?V?w??????-@U@@@@ A=AlAAAA BFBwBBBCCGCxCCCCC D9DjDDDDEFEtEEEEE FOF}FFFFFFGG.G:GjGGGG!HRH}HHHI6IcInI|IIIJJ)J>JRJbJnJJJJJK3KFKdKoKKKKK L3LQLbLLLLLLMM0MBMOMyMMMN1NbNNNNOFOcOOOOPDPuPPPPPPQQ)Q;QGQpQQQQRRARNR]RoR|RRRS4SfSSSSTTT.T^TTTTTUJUtUUUU!VFVSVVVVVVVVW9WEWvWWWWWWW XXBXsXXXX'Y;YvYYYYYZ.ZCZUZhZZZZZ[[#[<[T[z[[[[\#\0\?\a\q\}\\\\]]6]O]e]q]]]]^<^l^^^^^^^_H_s____ ``,`C`\`s`````a;amaaaa b8b9bHbkbubbbc0cXccccd(dKd^dpdddddeReeeee'fKfwfffffg;gGguggggg hh.h>hOh\hhhhhi&i;iNi_iqiiiiij/j\jjjkj~jjjk2kakkkklHlsllllllm(mRmmmmmnCnDn^nnnno>ojoooop%pMp|pppq;qjqqqqrHr]rrrrr(sYsssstt:tOtnt}t~ttttttttttttttttttttuQuuuuuuuuuv)v@vSviv~vvww*x+x8x:xExGx]xexnxxxyy+y-yKy0z1z`zbz~zzzzzz {|||||||||||}}}3~4~A~C~h~~~~~+4&).1Łȁւׂ(25̃׃ڃτąmn|efKLY[gs89FHTlΉЉ҉$&:OdyŋƋNjȋɋ "6LatՌ׌ٌی"#Z[mp͍ -956DPr’Β*~ŕȕ#.HIVvjklmnpWXqל;Xrڝ1;PfghI00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^ I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I00^I0 0^I0 0^I0 0^I0 0^I0 0^I0 0^I0 0^I0 0^I0 0^I0 0^I0 0^@0I00^I00^I00^I00^I00^I00^I00^I00^I00^@0I00^I00^I00^I00^I00^I00^I00^I00I00^I00^I00^I00^I00^@0I00^I00^I00^I00^@0I00^I00^I00^I00^@0I00^I00^I00^I00^@0I00^I00^@0I00^I00^I00^I00^ @<^I0 0^I0 0^I0 0^I0 0^ @L>^I0"0^I0"0^I0"0^ @T0^I0$0^I0$0^I0$0^I0$0^@0I0&0^I0&0^@0I0(0^I0(0^I0(0^I0(0^I0(0^I0(0^@0I0*0^@0I0,0^I0,0^I0,0^I0,0^I0,0^I0,0^I0,0^I0,0^@0I0.0^@0I000^I000^I000^I000^I000^I000^I000^I000^I000^I000^I000^@0I020^I020^I020^I020^I020^I020^I020^I020^I020^I020^I020^@0I040^@0I060^I060^I060^I060^I060^I060^I060^I060^I060^I060^I060^I060^I060^I060^I060^@0I080^@K0I0:0^I0:0^I0:0^I0:0^I0:0^I0:0^I0:0^I0:0^@K0I0<0^I0<0^I0<0^I0<0^I0<0^I0<0^I0<0^I0<0^I0<0^I0<0^@K0I0>0^@K0I0@0^@K0I0B0^I0B0^I0B0^I0B0^I0B0^@K0I0D0^I0D0^I0D0^I0D0^I0D0^@K0I0F0^I0F0^I0F0^I0F0^@0I0H0^I0H0^I0H0^@0I0J0^@0I0L0^I0L0^I0L0^I0L0^I0L0^I0L0^@0I0N0^I0N0^I0N0^I0N0^I0N0^I0N0^@0I0P0^I0P0^I0P0^I0P0^I0P0^@0I0R0^I0R0^I0R0^@0I0T0^I0T0^I0T0^I0T0^I0T0^I0T0^I0T0^I0T0^I0T0^@0I0V0^I0V0^@0I0X0^@0I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0^I0Z0 @0I00I0000i1|<N\3l|{֊U`djou{"  #%).16:g=3ADGjL!PoSVNZ!^'a0dHgjnq(ujy|}i~*03֊meK8Б&ȓՔZ95~HkW;gVXYZ[\]^_abcefghiklmnpqrstvwxyz|}~W?b$ӛH;iOg(H-f2$SY`̼cJb$9[e$D{0Cua@(  N  3  N  3    S ^A?.@pharmacyII}S`T}S`TIf  S 6A?@"$*, : ,J,!& $&E,E43& ; ;B"eG N 6R"6Rn%6R|16R9Mv8eG:JA~K/@A;PQ0S.S+N$!LH I 4)**~  S NA?.@88R`TR`T8N  3  B S  ?r  &$VtX &VXB $. T4!)t#t)4t _Toc110153929 _Toc110153930 Benazepril_ Narcotics:Aspirin_Derivatives$Nonsteroidal_anti-inflammatory_drugsMylantaAmoxicillin/clavulanate Azithromycin Dicloxacillin Doxycycline Erythromycin Isoniazid MinocyclineNitrofurantoin PenicillinTrimethoprim/sulfamethoxazole Phenytoin Tricyclics:SSRIs: AlprazolamHydrochlorothiazideSpironolactone Glyburide Alendronate AllopurinolDigoxin TheophyllineWarfarin Amiodaroneu:xy1z|C~~ׂf[HpDIX      *uDx)yUz|Z~Ƀ΄dS#M"Ub "* "W ") "X "Y "k "T: "<9 "W "W " DW "H "$/M "d/M "/M "$RQ "RQ "dRQ "$SQ "RQ "SQ "dSQ "SQ "$TQ "dTQ  ~~sstt:t:tFtIt         ss9t9tDtHtNtNt   > *urn:schemas-microsoft-com:office:smarttags PostalCode:*urn:schemas-microsoft-com:office:smarttagsStreet;*urn:schemas-microsoft-com:office:smarttagsaddressB*urn:schemas-microsoft-com:office:smarttagscountry-region9*urn:schemas-microsoft-com:office:smarttagsState=*urn:schemas-microsoft-com:office:smarttags PlaceType=*urn:schemas-microsoft-com:office:smarttags PlaceName8*urn:schemas-microsoft-com:office:smarttagsCity9*urn:schemas-microsoft-com:office:smarttagsplace ,! y 2 8 $&.GQSXz ltv~ ,9;C\egqenpw #-/5NU`jlu\dfm  k  6?AIes !*,3NUW_s :::::4iC`\@^`56CJOJ QJ o(hH.4i4i (УNVM  QQuuu~vww*x+xnxyyKy0z1z {|||||}}3~4~h~~~4)1ȁւׂ5ڃąmn|efKL89ȋɋ"#Z[͍956r*~ȕ.HIvmnpWXXgh@@@Unknown Gz Times New Roman5Symbol3& z Arial7&  Verdana5& zaTahomaWMSTT31834fab40O15706600WMSTT31834fab40O05602400WMSTT314a5525b5O05502400I& ??Arial Unicode MS9GaramondO1 CourierCourier New"1hƺQ Q ! 4aa3QHX)? Q2 APPENDIX CDONALD JOHNSONDONALD JOHNSON Oh+'0  < H T`hpx APPENDIX CDONALD JOHNSONNormalDONALD JOHNSON1Microsoft Office Word@@]@]՜.+,0$ hp  4RAINBOW CONSULTING & THERAPEUTIC MASSAGE & BODYWORK Qa  APPENDIX C Title  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F Ӭ]Data /1TableWordDocumentSummaryInformation(DocumentSummaryInformation8CompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q